<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1-316-20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2007
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MYCAMINE 50-10ML VIAL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MICAFUNGIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intramuscular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        382.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ASTELLAS PHARMA TECH. CO. LTD, (TAKAOKA PLANT)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ASTELLAS PHARMA TECH. CO. LTD, (TAKAOKA PLANT)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ASTELLAS PHARMA INC.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J02AX05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmacotherapeutic group:</p><p>&nbsp;</p><p>Micafungin is a broad spectrum antifungal agent originally developed by Astellas Pharmaceutical Inc. Japan which belongs to the echinocandin class. It has a significant activity against <em>Candida sp.</em>, and <em>Aspergillus sp. </em>the main causative fungi of deep seated mycosis. Micafungin exhibits potent <em>in vitro </em>activity against <em>Candida sp. </em>that are resistant to fluconazole or itraconazole. Micafungin is fungicidal against <em>Candida sp. </em>and inhibits germination and hyphal extension in <em>Aspergillus sp</em>. Micafungin also has potent protective or therapeutic effect against disseminated candidiasis, oral and esophageal candidiasis, disseminated aspergillosis and pulmonary aspergillosis.</p><p><strong>Mechanism of action: </strong>Micafungin non-competitively inhibits biosynthesis of 1,3-&szlig;-D- glucan which is an essential component of fungal cell walls.</p><p>&nbsp;</p><p>Therapeutic indications:</p><p>&nbsp;</p><p>Mycamine is indicated for the treatment of the following infections caused by <em>Aspergillus sp. </em>and <em>Candida sp.</em>: Fungemia, respiratory mycosis, gastrointestinal mycosis. Prophylaxis of <em>Aspergillus </em>and <em>Candida </em>infections in patients undergoing hematopoietic stem cell transplantation (HSCT).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Do not take Mycamine</u></p><p>&nbsp;</p><p>If you are hypersensitive to micafungin, to other echinocandins or any of the other ingredients of Mycamine.</p><p>&nbsp;</p><p>b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Take special care with Mycamine</u></p><p>&nbsp;</p><p>&bull;&nbsp; Micafungin sodium should be administered with care in the following patients:</p><p>1-&nbsp;&nbsp; Patients with a history of hypersensitivity to drugs</p><p>2-&nbsp;&nbsp; Patients with hepatic impairment (Administration of micafungin sodium may aggravate hepatic impairment.)</p><p>&nbsp;</p><p>&bull;&nbsp; Important Precautions:</p><p>1.&nbsp; Patients should be monitored carefully by conducting periodic liver function tests, etc. If any abnormalities are observed, appropriate measures, such as discontinuation of the product, should be taken. In addition, animal studies have shown that this product induces altered hepatocellular foci, some of which later formed tumors. See &rdquo;Other Clinically Significant Adverse Reactions&rdquo;.</p><p>2.&nbsp; Clinical studies have showed that hepatic function disorder occurred more frequently in children than in adults. Therefore careful attention should be paid when administering micafungin sodium to children.</p><p>3.&nbsp; If aspergillosis or candidiasis develops after the start of prophylaxis with micafungin sodium, patients should not continue administration and appropriate measures, such as switching or other products or increasing the dose should be taken.</p><p>4.&nbsp;&nbsp; When it becomes clear that the causative organism is not <em>Aspergillus sp. </em>or <em>candida sp.</em>, or whenit becomes clear that micafungin sodium is not effective, , appropriate measures such as switching to other products should be taken.</p><p>5.&nbsp;&nbsp; The duration of treatment with this drug should be limited to the minimum required for treatment of the disease.</p><p>&nbsp;</p><p>Aspergillosis and candidiasis (adults):</p><p>1-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As the safety of this product in increased doses up to 300 mg daily for severe or refractory infections has not been fully established, the product at these dose levels should be administered with caution such as close observation of the patient&rsquo;s condition</p><p>2-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For patients who weigh 50 kg or less, the dosage should not exceed 6 mg kg body weight daily.</p><p>&nbsp;</p><p>Prophylaxis of Aspergillus and Candida infections in pa-tients undergoing hematopoietic stem cell transplantation (adults):</p><p>1-&nbsp; Treatment with this product should be stopped when appropriate, such as when the neutrophil count re-covers to &ge;500/mm3</p><p>2- For patients who weigh 50 kg or less, the dosage should not exceed 1 mg (potency)/kg body weight daily.</p><p>&nbsp;</p><p>Aspergillosis and candidiasis (children):</p><p>1-&nbsp; As the safety of this product in increased doses up to 6 mg (potency)/kg daily for severe or refractory in-fections has not been fully established, precautions, such as close observation of the patient&rsquo;s condition, should be taken when administering the product at these dose levels [clinical experience with doses of 6 mg (potency)/kg daily is limited both in Japan and other countries.)].</p><p>2-&nbsp;&nbsp;&nbsp; For patients who weigh 50 kg or more, the dosage should not exceed 300 mg (potency) daily.</p><p>&nbsp;</p><p>Prophylaxis of Aspergillus and Candida infections in pa-tients undergoing hematopoietic stem cell transplantation (children):</p><p>1-&nbsp; Treatment with this product should be stopped when appropriate, such as when the neutrophil count re-covers to &ge;500/mm3</p><p>2- For patients who weigh 50 kg or more, the dosage should not exceed 50 mg (potency) daily.</p><p>&nbsp;</p><p>c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Taking other medicines, herbal or dietary supplements</u></p><p>Micafungin has a low potential for interactions with medicines metabolised via CYP3A mediated pathways.</p><p>&nbsp;</p><p>Exposure (AUC) of sirolimus was increased in the presence of micafungin (21%). Patients receiving sirolimus in combination with micafungin should be monitored for sirolimus toxicity and the sirolimus dosage should be adjusted if necessary.</p><p>&nbsp;</p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>&nbsp;</p><p>d.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Using Mycamine with food and drink</u></p><p>&nbsp;</p><p>Not applicable</p><p>&nbsp;</p><p>e.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Pregnancy and breast-feeding</u></p><p>&nbsp;</p><p><u>Pregnancy</u>: The safety of Micafungin sodium in pregnant women has not been established. Micafungin sodium should be administered in pregnant women or women who may possibly be pregnant only if the expected therapeutic benefits outweigh the possible risks associated with treatment.</p><p>&nbsp;</p><p><u>Breast-feeding</u>: In animal studies, micafungin sodium was found to be excreted in breast milk. Therefore, it is advisable to avoid using micafungin sodium in lactating mothers. If use of micafungin sodium is judged to be essential, breast feeding must be discontinued during treatment.</p><p>&nbsp;</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p>&nbsp;</p><p>f.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Driving and using machines</u></p><p>Not applicable</p><p>&nbsp;</p><p>g.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Important information about some of the ingredients of Mycamine</u></p><p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Adults Aspergillosis:</strong></p><p>For adults, the usual single daily dose is 50 &ndash; 150 mg of micafungin sodium infused intravenously once daily. The dosage can be increased according to the patient&rsquo;s condition for severe or refractory aspergillosis up to 300 mg / day.</p><p>Candidiasis:</p><p>For adults, the usual single daily dose is 50 mg of micafungin sodium infused intravenously once daily. The dosage can be increased according to the patient&rsquo;s condition for severe or refractory candidiasis up to 300 mg /day.</p><p><strong>Prophylaxis of <em>Aspergillus </em>and <em>Candida </em>Infections in patients undergoing HSCT:&nbsp; </strong>For adults, the usually single daily dose is 50 mg of micafungin sodium infused intravenously once daily.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Children Aspergillosis:</p><p>For children, the usual single daily dose is 1 &ndash; 3 mg /kg body weight of micafungin sodium. This product should be infused intravenously once daily. The dosage can be increased according to the patient&rsquo;s condition for severe or refractory aspergillosis up to 6 mg /kg daily.</p><p>Candidiasis:</p><p>For children, the usual single daily dose is 1 mg /kg of micafungin sodium. This product should be infused intravenously once daily. The dosage can be in-creased according to the patient&rsquo;s condition for severe or refractory candidiasis up to 6 mg /kg daily.</p><p><strong>Prophylaxis of <em>Aspergillus </em>and <em>Candida </em>infections in patients undergoing HSCT:</strong></p><p>For children, the single daily dose is 1 mg /kg of micafungin sodium. This product should be infused intravenously once daily.</p><p>The safety of this product in low birth weight infants and neonates has not been established. In clinical studies, the plasma drug concentration tended to be lower in low birth weight infants. Since clinical studies showed that hepatic function disorder occurred more frequently in children then in adults, great care should be taken when administering this product to children.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use in the Elderly</p><p>Since elderly patients often have reduced physiological function, dosage should be carefully determined and other appropriate measures should be considered.</p><p>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>If you use more Mycamine than you should</u></p><p>Your doctor monitors your response and condition to determine what dose of Mycamine is needed. However, if you are concerned that you may have been given too much Mycamine, speak to your doctor or another healthcare professional immediately.</p><p>b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>If you forget to use Mycamine</u></p><p>Your doctor monitors your response and condition to determine what Mycamine treatment is needed. However, if you are concerned that you may have missed a dose, speak to your doctor or another healthcare professional immediately.</p><p>c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>If you stop using Mycamine </u>Not applicable.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Clinically significant adverse reactions</strong></p><p><strong>Hematologic disorder: </strong>Leukopenia (incidence unknown*), neutropenia (incidence 1.1%), hemolytic anemia (including intravascular hemolysis; incidence unknown*), disseminated intravascular coagulation (incidence unknown) or thrombocytopenia may occur. Patients should be carefully monitored by periodic examination, etc. and appropriate measures such as discontinuation of treatment should be taken if such abnormalities are observed. In addition, haemolytic anemia may occur immediately after administration of this product, therefore appropriate measures, such as discontinuation of treatment, should be taken if hemolysis is observed.</p><p><strong>Shock, anaphylactoid reactions: </strong>Shock or anaphylactoid reactions (incidence unknown*) may occur. Patients should be carefully monitored and if abnormalities such as decreased blood pressure, oral cavity discomfort, dyspnea, generalized flushing, angioedema, or urticaria, etc. are observed, this product should be discontinued, and if necessary, appropriate measures such as maintenance of the airway or administration of adrenaline, steroids or antihistamines, etc. should be taken.</p><p><strong>Hepatic function disorder or jaundice: </strong>Hepatic function disorder with increased AST (GOT), ALT (GPT), gamma GT or ALP, etc., or jaundice may occur (incidence unknown*). Patients should be carefully monitored by periodic examination, etc. and appropriate measures such as discontinuation of treatment should be taken if such abnormalities are observed.</p><p><strong>Acute renal failure: </strong>Serious renal disorder such as acute renal failure may occur (incidence unknown*). Patients should be carefully monitored by periodic examination, etc. and appropriate measures such as discontinuation of treatment should be taken if such abnormalities are observed.</p><p><strong>Toxic epidermal necrolysis (TEN), oculomucocutaneous syndrome (Stevens-Johnson syndrome), erythema multiforme</strong>: Since toxic epidermal necrolysis, oculomucocutaneous syndrome, erythema mul-tiforme (incidence unknown*, each) may occur, patients should be observed carefully. If any abnormalities are observed during treatment, appropriate measures such as discontinuation of this product should be taken.</p><p><strong>*Incidence unknown: </strong>incidence is not calculated because of spontaneous reports.</p><p>b-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other adverse reactions</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&ge; 5%</p></td><td style="vertical-align:top"><p>&ge;0.1% - &lt; 5%</p></td><td style="vertical-align:top"><p>Incidence unknown</p></td></tr><tr><td style="vertical-align:top"><p>Hepatic</p></td><td style="vertical-align:top"><p>, increased ALT (GPT)</p></td><td style="vertical-align:top"><p>Increased AST (GOT) Increased ALP, Increased LDH, Increased gamma GT</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Metabolic</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p><p>Hyperkalamia, Hypokalemia,</p></td><td style="vertical-align:top"><p>Hypomagnesemia, hypocalcemia,</p></td></tr><tr><td style="vertical-align:top"><p>Hematologic</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Eosinophilia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Dermatologic</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rash</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Cardiovascular</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypertension, palpitation</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Diarrhea, loose stools</p></td><td style="vertical-align:top"><p>Vomiting, nausea,</p></td></tr><tr><td style="vertical-align:top"><p>Renal</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Increased&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; creatinine, Increased BUN</p></td><td style="vertical-align:top"><p>Decreased creatinine clearance</p></td></tr><tr><td style="vertical-align:top"><p>Others</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Phlebitis,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache, Arthritis, Vascular pain, Rigors</p></td><td style="vertical-align:top"><p>Increased&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CK (CPK), Increased blood myoglobin, Fever</p></td></tr></tbody></table><p><strong>Note: </strong>In case of occurrence of any serious adverse effects related to the use of this product, please contact Hikma Pharmaceuticals.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store below 30&ordm;C, away from light.</p><p>The reconstituted product may be stored in the original vial for up to 24 hours at room temperature, 25&deg; C (77&deg; F).</p><p>The diluted infusion should be protected from light and may be stored for up to 24 hours at room temperature, 25&deg; C (77&deg; F).</p><p>Keep medicament out of the reach of children</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>5.&nbsp;&nbsp; PRESENTATIONS</p><p>Vials.</p><p>MYCAMINE 50: 50 mg (potency) of Micafungin sodium Excipients: Lactose, Anhydrous citric acid, Sodium hydroxide</p><p>&nbsp;</p><p>DIRECTIONS FOR RECONSTITUTION AND DILUTION</p><p>Please read this entire section carefully before beginning reconstitution.</p><p>The diluent to be used for reconstitution and dilution is 0.9% Sodium Chloride Injection, USP (without a bacteriostatic agent). Alternatively, 5% Dextrose Injection, USP, may be used for reconstitution and dilution of MYCAMINE. Solutions for infusion are prepared as follows:</p><p>&nbsp;</p><p>Reconstitution:</p><p>MYCAMINE 50 mg vial</p><p>&nbsp;</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The plastic cap must be removed from the vial and the stopper disinfected with alcohol</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Five ml of sodium chloride 9mg/ml (0.9%) solution for infusion or glucose 50mg/ml (5%) solution for infusion (taken from a 100ml bottle/bag) should be aseptically and slowly injected into each vial along the inner wall. Although the concentrate will foam, every effort should be made to minimise the amount of foam generated.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The vial should be rotated gently. DO NOT SHAKE. The powder will dissolve completely. The concentrate should be used immediately. The vial is for single use only. Therefore please discard unused reconstituted concentrate immediately.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All of the reconstituted concentrate should be withdrawn from each vial and returned into the infusion bottle/bag from which it was originally taken. The diluted infusion solution should be used immediately. Chemical and physical in-use stability has been demonstrated for 96 hours at 25&deg;C when protected from light and diluted as described above.</p><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The infusion bottle/bag should be gently inverted to disperse the diluted solution but NOT agitated in order to avoid foaming. Do not use if the solultion is cloudy or has precipitated.</p><p>&nbsp;</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The infusion bottle/bag containing the diluted infusion solution should be inserted into a closable opaque bag for protection from light. It is not necessary to cover the infusion drip chamber or the tubing.</p><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After reconstitution and dilution, the solution should be administered by intravenous infusion over approximately 1 hour.</p><p>&nbsp;</p><p>PRECAUTIONS Concerning Use</p><p>Precaution in preparation: Do not shake the infusion bag strongly to dissolve micafungin sodium&nbsp; because it foams easily and the bubbles do no disappear easily.</p><p>Precaution during administration: Keep Mycamine away from direct sunlight since micafungin sodium is gradually decomposed by light. When it takes more than 6 hours from preparation to the end of infusion, protect the infusion bag from light. On the other hand, it is not necessary to protect the infusion tube from light.</p><p>Incompatibility: Precipitation may occur when micafungin sodium is dissolved concomitantly with other drugs.Further, micafungin sodium is unstable in basic solution, where potency of micafungin sodium may decrease.</p><p>The main drugs that cause precipitation immediately after combination with micafungin sodium are: Vancomycin hydrochloride, arbekacin sulfate, gentamicin sulfate, tobramycin, dibekacin sulfate, minocycline hydrochloride, ciprofloxacin, pazufloxacin mesilate, cimetidine, dobutamine hydrochloride, doxapram hydrochloride, pentazocine, nafamostat mesilate,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; gabexate&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mesilate,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thiamine&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disulfide/pyridoxine hydrochloride/hydroxocobalamin acetate, menatetrenone, freeze-dried pepsin treated human normal immunoglobulin, doxorubicin hydrochloride.</p><p>The main drugs, which reduce potency of micafungin sodium immediately after combination are: Ampicillin, sulfamethoxazole/trimethoprim, acyclovir, ganciclovir, acetazolamide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                PRESENTATIONS
Vials.
MYCAMINE 50: 50 mg (potency) of Micafungin sodium Excipients: Lactose, Anhydrous citric acid, Sodium hydroxide

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong></p><p>Astellas Pharma Inc.</p><p>5-1, Nihonbashi 2-Honcho, Chuo-ku, Tokyo 103-8411, Japan</p><p><strong>Manufacturer</strong></p><p>Astellas Pharma Tech Co., Ltd. Takaoka Plant 30 Toidesakae-machi, Takaoka city, Toyama 939- 1118 Japan</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in September 2018; version number 2.0.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ﻣﺠﻤﻮﻋﺔ اﻟﻤﻌﺎﻟﺠﺔ اﻟﺪواﺋﯿﺔ:</p><p>&nbsp;</p><p dir="RTL">ﻣﯿﻜﺎﻓﻨﺠﯿﻦ ﻋﺎﻣﻞ ﻣﻀﺎد ﻟﻠﻔﻄﺮﯾﺎت واﺳﻊ اﻟﻤﻔﻌﻮل، وﻗﺪ طﻮرﺗﮫ ﺷﺮﻛﮫ أﺳﺘﯿﻼس ﻓﺎرﻣﺎ اﻟﻤﺤﺪودة ﺑﺎﻟﯿﺎﺑﺎن، وﯾﻨﺘﻤﻲ إﻟﻰ اﻹﺗﺸﯿﻨﻮﻛﺎﻧﺪﯾﻨﺎت. ﻟﮫ ﺗﺄﺛﯿﺮ ﻗﻮي ﺿﺪ اﻟﻔﻄﺮﯾﺎت<em> اﻟﻤﺒﯿﻀﺔ واﻟﺮﺷﺎﺷﯿﺔ</em>، وھﻲ اﻟﻔﻄﺮﯾﺎت اﻷﺳﺎﺳﯿﺔ اﻟ ُﻤﺴ ِﺒّﺒﺔ ﻟﻠﻌﺪوى ﻣﺠﻤﻮﻋﺔ</p><p dir="RTL">&nbsp;اﻟﻌﻤﯿﻘﺔ.<em>&nbsp; ﻓﻲ&nbsp; اﻟﻤﺨﺘﺒﺮ،</em>&nbsp; ﯾﻈﮭﺮ&nbsp; ﻟﻤﯿﻜﺎﻓﻨﺠﻦ&nbsp; ﺗﺄﺛﯿﺮ&nbsp; ﻓﻌﺎل&nbsp; ﺿﺪ<em>&nbsp; اﻟﻔﻄﺮﯾﺎت&nbsp; اﻟﻤﺒﯿﻀﺔ</em>&nbsp; اﻟﻤﻘﺎ ّوﻣﺔ&nbsp; ﻟﻠﻔﻠﻮﻛﻮﻧﺎزول&nbsp; أو اﻟﻔﻄﺮﯾﺔ</p><p dir="RTL">ﻣﯿﻜﺎﻓﻨﺠﻦ ﻣﻀﺎد<em> ﻟﻠﻔﻄﺮﯾﺎت اﻟﻤﺒﯿﻀﺔ</em> وﯾﺜﺒﻂ اﻹﻧﺒﺎت واﻣﺘﺪاد اﻟﺨﯿﻂ اﻟﻔﻄﺮي ﻓﻲ<em> اﻟﻔﻄﺮﯾﺎت اﻟﺮﺷﺎﺷﯿﺔ</em>. ﺗﺄﺛﯿﺮ وﻗﺎﺋﻲ أو ﻋﻼﺟﻲ ذو ﻓﻌّﺎﻟﯿﺔ ﻋﺎﻟﯿﺔ ﻟﻤﺤﺎرﺑﺔ داء اﻟﻤﺒﯿﻀﺎت اﻟﻤﻨﺘﺜﺮة، وداء اﻟﻤﺒﯿﻀﺎت اﻟﻔﻤﻮﯾﺔ اﻹﯾﺘﺮاﻛﻮﻧﺎزول. وﺑﺎﻹﺿﺎﻓﺔ، ﻟﻤﯿﻜﺎﻓﻨﺠﻦ</p><p dir="RTL">واﻟﻤﺮﯾﺌﯿﺔ، وداء اﻟﺮﺷﺎﺷﯿﺎت اﻟﻤﻨﺘﺜﺮة وداء اﻟﺮﺷﺎﺷﯿﺎت اﻟﺮﺋﻮﯾﺔ. <strong>آﻟﯿﺔ&nbsp; اﻟﺘﺄﺛﯿﺮ:</strong> وﯾﺜﺒﻂ ﻣﯿﻜﺎﻓﻨﺠﻦ ﺑﻼ ﺗﻨﺎﻓﺴﯿﺔ ﻋﻤﻠﯿﺔ اﻻﺻﻄﻨﺎع اﻟﺤﯿﻮي ﻹﻧﺰﯾﻢ ﺑﯿﺘﺎ-دي ﺟﻠﻮﻛﺎن 1، 3، واﻟﺬي ﯾﺸﻜﻞ ﻣﻜﻮﻧًﺎ</p><p dir="RTL">أﺳﺎﺳﯿًﺎ ﻟﻠﺠﺪران اﻟﺨﻠﻮﯾﺔ ﻟﻠﻔﻄﺮﯾﺎت.</p><p>&nbsp;</p><p dir="RTL">دواﻋﻲ اﻻﺳﺘﻌﻤﺎل اﻟﻌﻼﺟﯿﺔ:</p><p>&nbsp;</p><p dir="RTL">ﻣﺎﯾﻜﺎﻣﯿﻦ ﻟﻤﻌﺎﻟﺠﺔ اﻟﻌﺪوى اﻟﻨﺎﺗﺠﺔ ﻋﻦ<em> اﻟﻔﻄﺮﯾﺎت اﻟﺮﺷﺎﺷﯿﺔ واﻟﻔﻄﺮﯾﺎت اﻟﻤﺒﯿﻀﺔ</em> اﻟﺘﺎﻟﯿﺔ: ﻓﻄﺮﯾﺎت اﻟﺪم، اﻟﺮﺋﻮﯾﺔ، واﻟﻌﺪوى اﻟﻔﻄﺮﯾﺔ اﻟﻤﻌﻮﯾﺔ. ﻟﻮﻗﺎﯾﺔ اﻟﻤﺮﺿﻰ اﻟﺨﺎﺿﻌﯿﻦ ﻟﺰراﻋﺔ اﻟﺨﻼﯾﺎ اﻟﺠﺬﻋﯿﺔ اﻟﻤﻜﻮﻧﺔ ﻟﻠﺪم ﯾﻮﺻﻰ ﺑﺎﺳﺘﻌﻤﺎل واﻟﻌﺪوى اﻟﻔﻄﺮﯾﺔ</p><p dir="RTL">(HSCT) ﻣﻦ ﻋﺪوى<em> </em><em>ا</em><em>ﻟﺮ</em><em>ﺷ</em><em>ﺎ</em><em>ﺷ</em><em>ﯿ</em><em>ﺔ</em><em> </em><em>و</em><em>ا</em><em>ﻟﻤﺒﯿ</em><em>ﻀ</em><em>ﺔ</em>.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;</strong></p><p dir="RTL">.a<u>&nbsp;&nbsp; ﻻ ﺗﺴﺘﻌﻤﻞ ﻣﺎﯾﻜﺎﻣﯿﻦ</u></p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">ﻣﻦ ﻣﻜﻮﻧﺎت ﻣﺎﯾﻜﺎﻣﻦ. يٍ</p><p>&nbsp;</p><p dir="RTL">إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ اﻟﺤﺴﺎﺳﯿﺔ اﻟﻤﻔﺮطﺔ ﺗﺠﺎه ﻣﯿﻜﺎﻓﺎﻧﺠﻦ، أو اﻹﺗﺸﯿﻨﻮﻛﺎﻧﺪﯾﻨﺎت اﻷﺧﺮى، أو أ</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>.</strong><strong>b</strong>&nbsp;&nbsp; <u>ﻛﻦ ﺣﺮﯾ</u><u>&nbsp;</u><u>&nbsp; ًﺼﺎ&nbsp;ﻋﻨﺪ اﺳﺘﻌﻤﺎل ﻣﺎﯾﻜﺎﻣﯿﻦ</u></p><p><strong>&nbsp;</strong></p><p>&bull; ﯾﺠﺐ اﺳﺘﻌﻤﺎل ﻣﺎﯾﻜﺎﻣﯿﻦ ﺑﺤﺮص ﻣﻊ اﻟﻤﺮﺿﻰ اﻟﺘﺎﻟﯿﯿﻦ:</p><p dir="RTL">-1 اﻟﻤﺮﺿﻰ اﻟﺬﯾﻦ ﻟﺪﯾﮭﻢ ﺗﺎرﯾﺦ ﻣﻊ ﻓﺮط اﻟﺤﺴﺎﺳﯿﺔ ﻣﻦ اﻷدوﯾﺔ</p><p dir="RTL">-2 اﻟﻤﺮﺿﻰ اﻟﺬﯾﻦ ﯾﻌﺎﻧﻮن ﻣﻦ ﻗﺼﻮر ﻓﻲ وظﺎﺋﻒ اﻟﻜﺒﺪ )ﻗﺪ ﯾﺆدى ﺗﻨﺎول ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ إﻟﻰ ﺗﻔﺎﻗﻢ اﻟﻘﺼﻮر ﻓﻲ</p><p dir="RTL">وظﺎﺋﻒ اﻟﻜﺒﺪ(.</p><p>&nbsp;</p><p>&bull; اﺣﺘﯿﺎطﺎت ﻣﮭﻤﺔ:</p><p dir="RTL">.1&nbsp;&nbsp;&nbsp;&nbsp; ﺗﺠﺐ ﻣﺮاﻗﺒﺔ اﻟﻤﺮﺿﻰ ﻋﻦ ﻛﺜﺐ ﻣﻦ ﺧﻼل اﺧﺘﺒﺎر وظﺎﺋﻒ اﻟﻜﺒﺪ ﺑﺎﻧﺘﻈﺎم، إﻟﻰ ﻏﯿﺮ ذﻟﻚ ﻣﻦ اﻹﺟﺮاءات.&nbsp; ﻓﻲ ﺣﺎل</p><p dir="RTL">ﻣﻼﺣﻈﺔ&nbsp;&nbsp; أي ﺷﻲء ﻏﯿﺮ طﺒﯿﻌﻲ، ﯾﺠﺐ اﺗﺨﺎذ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ، ﻣﺜﻞ اﻟﺘﻮﻗﻒ ﻋﻦ اﺳﺘﺨﺪام اﻟﻤﺴﺘﺤﻀﺮ.&nbsp; ﻓﻀ&nbsp;&nbsp; ًﻼ ﻋﻦ</p><p dir="RTL">ذﻟﻚ، ﻟﻘﺪ أﺛﺒﺘﺖ اﻟﺪراﺳﺎت اﻟﺤﯿﻮاﻧﯿﺔ أن ھﺬا اﻟﻤﺴﺘﺤﻀﺮ ﯾُﺤ&nbsp;ِﺪّث&nbsp;ﺗﻐﯿﯿ&nbsp;&nbsp; ًﺮا&nbsp;ﻓﻲ ﺑﺆر اﻟﺨﻼﯾﺎ اﻟﻜﺒﺪﯾﺔ، واﻟﺘﻲ ﯾﺘﻐﯿﺮ اﻟﺒﻌﺾ</p><p dir="RTL">ﻣﻨﮭﺎ وﯾﺸﻜﻞ ورﻣﺎ.&nbsp; اﻧﻈﺮ &quot;اﻟﺘﻔﺎﻋﻼت اﻟﻌﻜﺴﯿﺔ اﻟﺨﻄﯿﺮة اﻟﺴﺮﯾﺮﯾﺔ اﻷﺧﺮى.&quot;</p><p dir="RTL">.2 &nbsp;&nbsp;&nbsp;ﻟﻘﺪ أﺛﺒﺘﺖ اﻟﺪراﺳﺎت اﻟﺴﺮﯾﺮﯾﺔ أن ﺧﻠﻞ وظﺎﺋﻒ اﻟﻜﺒﺪ ﯾﺼﯿﺐ اﻷطﻔﺎل أﻛﺜﺮ ﻣﻦ اﻟﺮاﺷﺪﯾﻦ ﺑﻮﺗﯿﺮة أﻛﺒﺮ. ﻟﺬﻟﻚ، ﯾﺠﺐ</p><p dir="RTL">إﯾﻼء ﺑﺎﻟﻎ اﻻھﺘﻤﺎم ﻋﻨﺪ إﻋﻄﺎء ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﺎﻧﺠﻦ ﻟﻸطﻔﺎل.</p><p dir="RTL">.3 &nbsp;ﻓﻲ ﺣﺎل ظﮭﻮر اﻟﺮﺷﺎﺷﯿﺔ أو اﻟﻤﺒﯿﻀﺎت ﺑﻌﺪ اﺳﺘﻌﻤﺎل ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﻟﻠﻮﻗﺎﯾﺔ، ﯾﺘﻌﯿﻦ ﻋﻠﻰ اﻟﻤﺮﺿﻰ اﻟﺘﻮﻗﻒ ﻋﻦ</p><p dir="RTL">ﺗﻨﺎول اﻟﺪواء، واﺗﺨﺎذ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ، ﻣﺜﻞ اﺳﺘﺒﺪال اﻟﻤﺴﺘﺤﻀﺮ أو اﺳﺘﺨﺪام اﻟﻤﺴﺘﺤﻀﺮات اﻷﺧﺮى أو زﯾﺎدة</p><p dir="RTL">اﻟﺠﺮﻋﺔ.</p><p dir="RTL">ﯾﺘﺒﯿﱠﻦ أن اﻟﻜﺎﺋﻨﺎت اﻟﻤﺴﺒّﺒﺔ ﻟﻠﻤﺮض ﻟﯿﺴﺖ<em> </em><em>اﻟ</em><em>ﻔ</em><em>ﻄ</em><em>ﺮ</em><em>ﯾ</em><em>ﺎ</em><em>ت</em><em> </em><em>اﻟ</em><em>ﺮ</em><em>ﺷ</em><em>ﺎ</em><em>ﺷ</em><em>ﺔ</em> أو<em> </em><em>اﻟ</em><em>ﻔ</em><em>ﻄ</em><em>ﺮﯾ</em><em>ﺎ</em><em>ت</em><em> </em><em>ا</em><em>ﻟﻤﺒﯿ</em><em>ﻀ</em><em>ﺔ</em>، أو ﻋﻨﺪﻣﺎ ﺗﺘﻀﺢ ﻋﺪم .4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﻋﻨﺪﻣﺎ</p><p dir="RTL">ﻓﺎﻋﻠﯿﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ، ﯾﺠﺐ اﺗﺨﺎذ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ ﻣﺜﻞ اﺳﺘﺒﺪال اﻟﻤﺴﺘﺤﻀﺮ أو اﻻﻧﺘﻘﺎل إﻟﻰ اﺳﺘﺨﺪام</p><p dir="RTL">اﻟﻤﺴﺘﺤﻀﺮات اﻷﺧﺮى.</p><p dir="RTL">.5&nbsp; ﯾﺠﺐ أن ﺗﻘﺘﺼﺮ اﻟﻤﺪة اﻟﻌﻼﺟﯿﺔ ﻋﻠﻰ اﻟﺤﺪ اﻷدﻧﻰ اﻟﻤﻄﻠﻮب ﻟﻤﻌﺎﻟﺠﺔ اﻟﻤﺮض.</p><p>&nbsp;</p><p dir="RTL"><strong>داء اﻟﺮﺷﺎﺷﯿﺎت وداء اﻟﻤﺒﯿﻀﺎت )اﻟﺒﺎﻟﻐﯿﻦ:( </strong>&nbsp;&nbsp;&nbsp;-1 ﻷن ﻧﺴﺒﺔ أﻣﺎن ھﺬا اﻟﻤﻨﺘﺞ ﻣﻊ اﻟﺠﺮﻋﺎت اﻟﻤﺮﺗﻔﻌﺔ اﻟﺘﻲ ﺗﺼﻞ إﻟﻰ 300 ﻣﻠﺠﻢ ﯾﻮﻣﯿًﺎ ﻟﻤﻌﺎﻟﺠﺔ اﻟﻌﺪوى اﻟﺸﺪﯾﺪة أو اﻟﻤﺴﺘﻌﺼﯿﺔ ﻟﻢ ﺗُﺤﺪﱠد&nbsp;ﻛﻠﯿًﺎ، ﯾﺠﺐ اﺗﺨﺎذ اﻻﺣﺘﯿﺎطﺎت ﻋﻨﺪ ﺗﻨﺎول ﻣﺜﻞ ھﺬه اﻟﻤﺴﺘﻮﯾﺎت ﻣﻦ اﻟﺠﺮﻋﺎت ﻟﻠﻤﺴﺘﺤﻀﺮ. وﯾﻤﻜﻦ ﺗﻨﻔﯿﺬ</p><p dir="RTL">ذﻟﻚ، ﻋﻠﻰ ﺳﺒﯿﻞ اﻟﻤﺜﺎل، ﻣﻦ ﺧﻼل ﻣﺮاﻗﺒﺔ ﺣﺎﻟﺔ اﻟﻤﺮﯾﺾ ﻋﻦ ﻛﺜﺐ.</p><p dir="RTL">-2 ﻟﻠﻤﺮﺿﻰ ﺑﻮزن 50 ﻛﺠﻢ أو أﻗﻞ، ﯾﺠﺐ أ&nbsp; ﱠﻻ&nbsp;ﺗﺘﺠﺎوز اﻟﺠﺮﻋﺔ 6 ﻣﻠﺠﻢ ﻟﻜﻞ ﻛﺠﻢ ﻣﻦ وزن اﻟﺠﺴﻢ ﯾﻮﻣﯿًﺎ.</p><p>&nbsp;</p><p>ﻟﻮﻗﺎﯾﺔ اﻟﻤﺮﺿﻰ اﻟﺨﺎﺿﻌﯿﻦ ﻟﺰراﻋﺔ اﻟﺨﻼﯾﺎ اﻟﺠﺬﻋﯿﺔ اﻟﻤﻜﻮﻧﺔ ﻟﻠﺪم ﻣﻦ داء اﻟﺮﺷﺎﺷﯿﺎت وداء اﻟﻤﺒﯿﻀﺎت )اﻟﺒﺎﻟﻐﯿﻦ:(</p><p dir="RTL">-1 ﯾﺠﺐ إﯾﻘﺎف اﻟﻤﻌﺎﻟﺠﺔ ﺑﮭﺬا اﻟﻤﺴﺘﺤﻀﺮ ﻓﻲ اﻟﻮﻗﺖ اﻟﻤﻨﺎﺳﺐ، ﻋﻠﻰ ﺳﺒﯿﻞ اﻟﻤﺜﺎل، ﻋﻨﺪﻣﺎ ﯾﺮﺟﻊ ﻋﺪد اﻟﺨﻼﯾﺎ اﻟﻤﺘﻌﺎدﻟﺔ إﻟﻰ</p><p dir="RTL">/500&le;ﻣﻢ3 ﻣﺮة أﺧﺮى</p><p dir="RTL">-2 ﻟﻠﻤﺮﺿﻰ ﺑﻮزن 50 ﻛﺠﻢ أو أﻗﻞ، ﯾﺠﺐ أ&nbsp;ﱠﻻ ﺗﺘﺠﺎوز اﻟﺠﺮﻋﺔ 1 ﻣﻠﺠﻢ )ﻗﻮﯾﺔ اﻟﻤﻔﻌﻮل/(ﻛﺠﻢ ﻣﻦ وزن اﻟﺠﺴﻢ ﯾﻮﻣﯿًﺎ.</p><p>&nbsp;</p><p>داء اﻟﺮﺷﺎﺷﯿﺎت وداء اﻟﻤﺒﯿﻀﺎت )اﻷطﻔﺎل:(</p><p>&nbsp;</p><p dir="RTL">-1 ﻷن ﻧﺴﺒﺔ أﻣﺎن ھﺬا اﻟﻤﻨﺘﺞ ﻣﻊ اﻟﺠﺮﻋﺎت اﻟﻤﺮﺗﻔﻌﺔ اﻟﺘﻲ ﺗﺼﻞ إﻟﻰ 6 ﻣﻠﺠﻢ )ﻗﻮﯾﺔ اﻟﻤﻔﻌﻮل/(ﻛﺠﻢ ﯾﻮﻣﯿًﺎ ﻟﻤﻌﺎﻟﺠﺔ اﻟﻌﺪوى</p><p dir="RTL">اﻟﺸﺪﯾﺪة أو اﻟﻤﺴﺘﻌﺼﯿﺔ ﻟﻢ ﺗُﺤﺪﱠد ﻛﻠﯿًﺎ، ﯾﺠﺐ اﺗﺨﺎذ اﻻﺣﺘﯿﺎطﺎت ﻋﻨﺪ ﺗﻨﺎول ﻣﺜﻞ ھﺬه اﻟﻤﺴﺘﻮﯾﺎت ﻣﻦ اﻟﺠﺮﻋﺎت ﻟﻠﻤﺴﺘﺤﻀﺮ. وﯾﻤﻜﻦ إﺟﺮاء ذﻟﻚ، ﻋﻠﻰ ﺳﺒﯿﻞ اﻟﻤﺜﺎل، ﻣﻦ ﺧﻼل ﻣﺮاﻗﺒﺔ ﺣﺎﻟﺔ اﻟﻤﺮﯾﺾ ﻋﻦ ﻛﺜﺐ ]ﯾﻮﺟﺪ ﺣﺪ ﻟﻠﺘﺠﺎرب اﻟﺴﺮﯾﺮﯾﺔ اﻟﻤﺘﻌﻠﻘﺔ</p><p dir="RTL">ﺑﺘﻨﺎول اﻟﺠﺮﻋﺎت اﻟﺘﻲ ﺗﺒﻠﻎ 6 ﻣﻠﺠﻢ )ﻗﻮﯾﺔ اﻟﻤﻔﻌﻮل/(ﻛﺠﻢ ﯾﻮﻣﯿًﺎ، وذﻟﻚ ﻓﻲ اﻟﯿﺎﺑﺎن واﻟﺒﻠﺪان اﻷﺧﺮى.[</p><p dir="RTL">-2 ﻟﻠﻤﺮﺿﻰ ﺑﻮزن 50 ﻛﺠﻢ أو أﻛﺜﺮ، ﯾﺠﺐ أﻻ ﺗﺘﺠﺎوز اﻟﺠﺮﻋﺔ 300 ﻣﻠﺠﻢ )ﻗﻮﯾﺔ اﻟﻤﻔﻌﻮل( ﯾﻮﻣﯿًﺎ.</p><p>&nbsp;</p><p>ﻟﻮﻗﺎﯾﺔ اﻟﻤﺮﺿﻰ اﻟﺨﺎﺿﻌﯿﻦ ﻟﺰراﻋﺔ اﻟﺨﻼﯾﺎ اﻟﺠﺬﻋﯿﺔ اﻟﻤﻜﻮﻧﺔ ﻟﻠﺪم ﻣﻦ ﻋﺪوى اﻟﺮﺷﺎﺷﯿﺔ واﻟﻤﺒﯿﻀﺎت )اﻷطﻔﺎل:(</p><p dir="RTL">-1 ﯾﺠﺐ إﯾﻘﺎف اﻟﻤﻌﺎﻟﺠﺔ ﺑﮭﺬا اﻟﻤﺴﺘﺤﻀﺮ ﻓﻲ اﻟﻮﻗﺖ اﻟﻤﻨﺎﺳﺐ، ﻋﻠﻰ ﺳﺒﯿﻞ اﻟﻤﺜﺎل، ﻋﻨﺪﻣﺎ ﯾﺮﺟﻊ ﻋﺪد اﻟﺨﻼﯾﺎ اﻟﻤﺘﻌﺎدﻟﺔ إﻟﻰ</p><p dir="RTL">/500&le;ﻣﻢ3 ﻣﺮة أﺧﺮى</p><p dir="RTL">-2 ﻟﻠﻤﺮﺿﻰ ﺑﻮزن 50 ﻛﺠﻢ أو أﻛﺜﺮ، ﯾﺠﺐ أﻻ ﺗﺘﺠﺎوز اﻟﺠﺮﻋﺔ 50 ﻣﻠﺠﻢ )ﻗﻮﯾﺔ اﻟﻤﻔﻌﻮل( ﯾﻮﻣﯿًﺎ.</p><p>&nbsp;</p><p dir="RTL">.c<u> &nbsp;اﺳﺘﻌﻤﺎل اﻷدوﯾﺔ اﻷﺧﺮى أو اﻷﻋﺸﺎب أو اﻟﻤﻜﻤﻼت اﻟﻐﺬاﺋﯿﺔ</u></p><p dir="RTL">ﯾﺘﻔﺎﻋﻞ ﻣﯿﻜﺎﻓﻨﺠﻦ ﻣﻊ اﻷدوﯾﺔ اﻟﺘﻲ ﯾﺘﻢ ﺗﺄﯾﻀﮭﺎ ﺑﻮاﺳﻄﺔ ﻣﺴﺎرات اﻟﺴﯿﺘﻮﻛﺮوم CYP3A ﺗﻔﺎﻋﻼً&nbsp;ﺿﻌﯿﻔًﺎ.</p><p>&nbsp;</p><p dir="RTL">ارﺗﻔﻌﺖ&nbsp; ﻧﺴﺒﺔ ﺗﻌﺮض&nbsp; اﻟﺴﯿﺮوﻟﯿﻤﻮس&nbsp; )اﻟﻤﻨﻄﻘﺔ ﺗﺤﺖ اﻟﻤﻨﺤﻨﻰ( ﺑﻨﺴﺒﺔ&nbsp; (%21)&nbsp; ﻓﻲ&nbsp; وﺟﻮد&nbsp; اﻟﻤﯿﻜﺎﻓﻨﺠﻦ. ﺗﺠﺐ ﻣﺮاﻗﺒﺔ</p><p>&nbsp;</p><p dir="RTL">ﺼﺎ ﻋﻦ إﺻﺎﺑﺘﮭﻢ ﺑﺴﻤﯿﺔ اﻟﺴﯿﺮوﻟﯿﻤﻮس، وﯾﺠﺐ ﺗﻌﺪﯾﻞ ﺟﺮﻋﺔ</p><p>&nbsp;</p><p dir="RTL">اﻟﻤﺮﺿﻰ&nbsp; اﻟﺬﯾﻦ ﯾﺘﻠﻘﻮن اﻟﺴﯿﺮوﻟﯿﻤﻮس ﻣﻊ اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﻓﺤ</p><p dir="RTL">اﻟﺴﯿﺮوﻟﯿﻤﻮس إذا ﻟﺰم اﻷﻣﺮ.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">ي&nbsp; أدوﯾﺔ أﺧﺮى أو ﻛﻨﺖ ﻗﺪ اﺳﺘﻌﻤﻠﺘﮭﺎ ﻣﺆﺧ&nbsp; ًﺮا،&nbsp;ﺑﻤﺎ ﯾﺘﻀﻤﻦ اﻷدوﯾﺔ</p><p>&nbsp;</p><p dir="RTL">ﯾُﺮﺟﻰ إﺧﺒﺎر اﻟﻄﺒﯿﺐ أو اﻟﺼﯿﺪﻟﻲ إذا ﻛﻨﺖ ﺗﺴﺘﻌﻤﻞ أ</p><p dir="RTL">اﻟﺘﻲ ﯾﻤﻜﻦ اﻟﺤﺼﻮل ﻋﻠﯿﮭﺎ دون وﺻﻔﺔ طﺒﯿﺔ.</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">.d<u>&nbsp; اﺳﺘﻌﻤﺎل ﻣﺎﯾﻜﺎﻣﯿﻦ ﻣﻊ اﻷطﻌﻤﺔ واﻟﻤﺸﺮوﺑﺎت</u></p><p>&nbsp;</p><p dir="RTL">ﻻ ﯾﻮﺟﺪ</p><p>&nbsp;</p><p dir="RTL">.e<u>&nbsp;&nbsp; اﻟﺤﻤﻞ واﻟﺮﺿﺎﻋﺔ اﻟﻄﺒﯿﻌﯿﺔ</u></p><p>&nbsp;</p><p dir="RTL"><u>اﻟﺤﻤﻞ</u>: ﻟﻢ ﯾﺘﻢ اﻟﺘﺄﻛﺪ ﻣﻦ ﻧﺴﺒﺔ أﻣﺎن ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﻣﻊ اﻟﻨﺴﺎء اﻟﺤﻮاﻣﻞ.<u> </u>ﻻ ﯾﺠﺐ ﻋﻠﻰ اﻟﻨﺴﺎء اﻟﺤﻮاﻣﻞ أو اﻟﻤﺤﺘﻤﻞ ﻟﮭﺎ أن ﺗﻜﻮن ﺣﺎﻣﻞ أن ﺗﺘﻨﺎول ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ، إﻻ إذا ﻛﺎﻧﺖ اﻟﻤﺰاﯾﺎ اﻟﻌﻼﺟﯿﺔ</p><p dir="RTL">اﻟﻤﺘﻮﻗﻌﱠﺔ ﺗﻔﻮق اﻟﻤﺨﺎطﺮ اﻟﻤﺤﺘﻤﻠﺔ اﻟﻤﺮﺗﺒﻄﺔ ﺑﺎﻟﻌﻼج.</p><p>&nbsp;</p><p dir="RTL"><u>اﻟﺮﺿﺎﻋﺔ اﻟﻄﺒﯿﻌﯿﺔ</u>: ﻓﻲ اﻟﺪراﺳﺎت اﻟﺤﯿﻮاﻧﯿﺔ، ﺗ&nbsp; ﱠﺒﯿﻦ أﻧﮫ ﯾﺘﻢ إﻓﺮاز ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﻓﻲ ﻟﺒﻦ اﻷم. ﻟﺬﻟﻚ، ﯾﻨﺼﺢ اﻷﻣﮭﺎت</p><p dir="RTL">اﻟﻤﺮﺿﻌﺎت ﺑﻌﺪم ﺗﻨﺎول ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ. إذا أﺧﺒﺮ اﻟﻄﺒﯿﺐ أن ﺗﻨﺎول ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﺿﺮوري، ﻓﯿﺠﺐ اﻟﺘﻮﻗﻒ</p><p dir="RTL">ﻋﻦ اﻹرﺿﺎع أﺛﻨﺎء ﻓﺘﺮة اﻟﻌﻼج.</p><p>&nbsp;</p><p dir="RTL">ﯾﻨﺒﻐﻲ اﺳﺘﺸﺎرة اﻟﻄﺒﯿﺐ أو اﻟﺼﯿﺪﻟﻲ ﻗﺒﻞ اﺳﺘﻌﻤﺎل أي دواء.</p><p>&nbsp;</p><p dir="RTL">.f&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>اﻟﻘﯿﺎدة واﺳﺘﻌﻤﺎل اﻵﻻت</u></p><p dir="RTL">ﻻ ﯾﻮﺟﺪ</p><p>&nbsp;</p><p dir="RTL">.g<u> &nbsp;ﻣﻌﻠﻮﻣﺎت ﻣﮭﻤﺔ ﺣﻮل ﺑﻌﺾ ﻣﻜﻮﻧﺎت ﻣﺎﯾﻜﺎﻣﯿﻦ</u></p><p dir="RTL">ﻻ ﯾﻮﺟﺪ</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;</strong></p><p dir="RTL"><strong>.1 &nbsp;اﻟﺒﺎﻟﻐﻮن</strong></p><p>&nbsp;</p><p dir="RTL"><strong>داء اﻟﺮﺷﺎﺷﯿﺎت:</strong></p><p dir="RTL">ﺑﺎﻟﻨﺴﺒﺔ إﻟﻰ اﻟﺒﺎﻟﻐﯿﻦ، ﺗﻜﻮن ﺟﺮﻋﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ اﻟﯿﻮﻣﯿﺔ اﻟﻤﻌﺘﺎدة 50 &ndash; 150 ﻣﻠﺠﻢ، وﺗﺆﺧﺬ ورﯾﺪﯾًﺎ ﻣﺮة واﺣﺪة ﻛﻞ</p><p dir="RTL">ﯾﻮم. ﯾﻤﻜﻦ ﺗﺰوﯾﺪ اﻟﺠﺮﻋﺔ ﺣﺘﻰ 300 ﻣﻠﺠﻢ ﻓﻲ اﻟﯿﻮم ﺑﺤﺴﺐ ﺣﺎﻟﺔ اﻟﻤﺮﯾﺾ اﻟﻤﺼﺎب ﺑﺪاء اﻟﺮﺷﺎﺷﯿﺎت اﻟﺤﺎدة أو اﻟﻤﺴﺘﻌﺼﻰ.</p><p>داء اﻟﻤﺒﯿﻀﺎت:</p><p dir="RTL">ﺑﺎﻟﻨﺴﺒﺔ إﻟﻰ اﻟﺒﺎﻟﻐﯿﻦ، ﺗﻜﻮن ﺟﺮﻋﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ اﻟﯿﻮﻣﯿﺔ اﻟﻮاﺣﺪة اﻟﻤﻌﺘﺎدة 50 ﻣﻠﺠﻢ، وﺗﺆﺧﺬ ورﯾﺪﯾًﺎ ﻣﺮة واﺣﺪة ﻛﻞ</p><p dir="RTL">ﯾﻮم. ﯾﻤﻜﻦ ﺗﺰوﯾﺪ اﻟﺠﺮﻋﺔ ﺣﺘﻰ 300 ﻣﻠﺠﻢ ﻓﻲ اﻟﯿﻮم ﺑﺤﺴﺐ ﺣﺎﻟﺔ اﻟﻤﺮﯾﺾ اﻟﻤﺼﺎب ﺑﺪاء اﻟﻤﺒﯿﻀﺎت اﻟﺤﺎدة أو اﻟﻤﺴﺘﻌﺼﯿﺔ.</p><p dir="RTL"><strong>ﻟﻮ</strong><strong>ﻗﺎﯾ</strong><strong>ﺔ اﻟﻤﺮﺿﻰ ﺑﻌﺪوﺗﻲ</strong><strong><em> </em></strong><strong><em>اﻟ</em></strong><strong><em>ﺮ</em></strong><strong><em>ﺷ</em></strong><strong><em>ﺎ</em></strong><strong><em>ﺷ</em></strong><strong><em>ﯿ</em></strong><strong><em>ﺎ</em></strong><strong><em>ت</em></strong><strong><em> </em></strong><strong><em>و</em></strong><strong><em>ا</em></strong><strong><em>ﻟ</em></strong><strong><em>ﻤ</em></strong><strong><em>ﺒﯿ</em></strong><strong><em>ﻀ</em></strong><strong><em>ﺎ</em></strong><strong><em>ت</em></strong><strong> اﻟﺨﺎﺿﻌﯿﻦ ﻟﺰراﻋﺔ اﻟﺨﻼﯾﺎ اﻟﺠﺬﻋﯿﺔ اﻟﻤﻜﻮﻧﺔ ﻟﻠﺪم :(HSCT)</strong></p><p dir="RTL">ﺑﺎﻟﻨﺴﺒﺔ إﻟﻰ اﻟﺒﺎﻟﻐﯿﻦ، ﺗﻜﻮن ﺟﺮﻋﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ اﻟﯿﻮﻣﯿﺔ اﻟﻮاﺣﺪة اﻟﻤﻌﺘﺎدة 50 ﻣﻠﺠﻢ، وﺗﺆﺧﺬ ورﯾﺪﯾًﺎ ﻣﺮة واﺣﺪة ﻛﻞ</p><p dir="RTL">ﯾﻮم.</p><p>&nbsp;</p><p>.2 &nbsp;اﻷطﻔﺎل</p><p dir="RTL"><strong>داء اﻟﺮﺷﺎﺷﯿﺎت: </strong>ﺑﺎﻟﻨﺴﺒﺔ إﻟﻰ اﻷطﻔﺎل، ﺗﻜﻮن ﺟﺮﻋﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ اﻟﯿﻮﻣﯿﺔ اﻟﻤﻌﺘﺎدة 1 &ndash; 3 ﻣﻠﺠﻢ/ﻛﺠﻢ ﻣﻦ وزن اﻟﺠﺴﻢ. ﯾﺠﺐ أﺧﺬ ھﺬا&nbsp;&nbsp; اﻟﻤﺴﺘﺤﻀﺮ ورﯾﺪﯾًﺎ وﻟﻤﺮة واﺣﺪة ﻛﻞ ﯾﻮم. ﯾﻤﻜﻦ ﺗﺰوﯾﺪ اﻟﺠﺮﻋﺔ ﺣﺘﻰ 6 ﻣﻠﺠﻢ/ﻛﺠﻢ ﻓﻲ اﻟﯿﻮم ﺑﺤﺴﺐ ﺣﺎﻟﺔ اﻟﻤﺮﯾﺾ</p><p dir="RTL">اﻟﻤﺼﺎب ﺑﺪاء اﻟﺮﺷﺎﺷﯿﺎت اﻟﺤﺎدة أو اﻟﻤﺴﺘﻌﺼﯿﺔ.</p><p dir="RTL"><strong>داء اﻟﻤﺒﯿﻀﺎت: </strong>ﺑﺎﻟﻨﺴﺒﺔ إﻟﻰ اﻷطﻔﺎل، ﺗﻜﻮن ﺟﺮﻋﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ اﻟﯿﻮﻣﯿﺔ اﻟﻤﻌﺘﺎدة 1 ﻣﻠﺠﻢ/ﻛﺠﻢ. ﯾﺠﺐ أﺧﺬ ھﺬا اﻟﻤﺴﺘﺤﻀﺮ ورﯾﺪﯾًﺎ وﻟﻤﺮة&nbsp; واﺣﺪة ﻛﻞ ﯾﻮم. ﯾﻤﻜﻦ زﯾﺎدة اﻟﺠﺮﻋﺔ ﺣﺘﻰ 6 ﻣﻠﺠﻢ/ﻛﺠﻢ ﻓﻲ اﻟﯿﻮم ﺑﺤﺴﺐ ﺣﺎﻟﺔ اﻟﻤﺮﯾﺾ اﻟﻤﺼﺎب ﺑﺪاء اﻟﻤﺒﯿﻀﺎت</p><p dir="RTL">اﻟﺤﺎدة أو اﻟﻤﺴﺘﻌﺼﯿﺔ.</p><p dir="RTL"><strong>اﻟﻤ</strong><strong>ﺮﺿﻰ ﺑﻌﺪوﺗﻲ</strong><strong><em> اﻟﺮ ﺷﺎ ﺷﯿﺎت واﻟﻤﺒﯿﻀﺎت</em></strong><strong> اﻟﺨﺎﺿﻌﯿﻦ ﻟﺰراﻋﺔ اﻟﺨﻼﯾﺎ اﻟﺠﺬﻋﯿﺔ اﻟﻤﻜﻮﻧﺔ ﻟﻠﺪم :(HSCT) ﻟﻮﻗﺎﯾﺔ</strong></p><p dir="RTL">ﺑﺎﻟﻨﺴﺒﺔ&nbsp; إﻟﻰ اﻷطﻔﺎل، ﺗﻜﻮن ﺟﺮﻋﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ اﻟﯿﻮﻣﯿﺔ 1 ﻣﻠﺠﻢ/ﻛﺠﻢ. ﯾﺠﺐ أﺧﺬ ھﺬا اﻟﻤﺴﺘﺤﻀﺮ ورﯾﺪﯾًﺎ وﻟﻤﺮة</p><p dir="RTL">واﺣﺪة ﻛﻞ ﯾﻮم.</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">ﻟﻢ ﯾﺘﻢ اﻟﺘﺤﻘﻖ ﻣﻦ أﻣﺎن ھﺬا اﻟﻤﻨﺘﺞ ﻣﻊ اﻟ&nbsp; ُﺮﺿﻊ وﺣﺪﯾﺜﻲ اﻟﻮﻻدة ﻣﻨﺨﻔﻀﻲ اﻟﻮزن. ﻓﻲ اﻟﺪراﺳﺎت اﻟﺴﺮﯾﺮﯾﺔ، ﻣﺎﻟﺖ ﻧﺴﺒﺔ</p><p dir="RTL">ﺗﺮﻛﯿﺰ&nbsp;&nbsp; اﻟﺒﻼزﻣﺎ ﻓﻲ اﻟﺪواء إﻟﻰ أن ﺗﻜﻮن ﻣﻨﺨﻔﻀﺔ ﻣﻊ اﻟ&nbsp; ُﺮﺿﻊ&nbsp;ﻣﻨﺨﻔﻀﻲ اﻟﻮزن. وﻧﻈ&nbsp;&nbsp; ًﺮا&nbsp;ﻹﺛﺒﺎت اﻟﺪراﺳﺎت اﻟﺴﺮﯾﺮﯾﺔ أن</p><p dir="RTL">ﺧﻠﻞ وظﺎﺋﻒ اﻟﻜﺒﺪ ﯾﺼﯿﺐ اﻷطﻔﺎل أﻛﺜﺮ ﻣﻦ اﻟﺒﺎﻟﻐﯿﻦ ﺑﻮﺗﯿﺮة أﻛﺒﺮ، ﻓﯿﺠﺐ إﯾﻼء ﺑﺎﻟﻎ اﻻھﺘﻤﺎم ﻋﻨﺪ إﻋﻄﺎء ﺻﻮدﯾﻮم</p><p dir="RTL">اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﻟﻸطﻔﺎل.</p><p>&nbsp;</p><p>.3 &nbsp;اﻻﺳﺘﺨﺪام ﻣﻊ ﻛﺒﺎر اﻟﺴﻦ</p><p dir="RTL">ﺑﻤﺎ أن ﻛﺒﺎر اﻟﺴﻦ ﻟﺪﯾﮭﻢ وظﯿﻔﺔ ﻓﺴﯿﻮﻟﻮﺟﯿﺔ أﻗﻞ، ﯾﺠﺐ ﺗﺤﺪﯾﺪ اﻟﺠﺮﻋﺔ ﺑﻌﻨﺎﯾﺔ، وﯾﻨﺒﻐﻰ وﺿﻊ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ اﻷﺧﺮى ﺑﻌﯿﻦ</p><p dir="RTL">اﻻﻋﺘﺒﺎر.</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">.a<u> &nbsp;إن اﺳﺘﺨﺪﻣﺖ ﻛﻤﯿﺔ أﻛﺒﺮ ﻣﻤﺎ ﯾﺠﺐ ﻣﻦ ﻣﺎﯾﻜﺎﻣﯿﻦ</u></p><p dir="RTL">ﯾﺮاﻗﺐ اﻟﻄﺒﯿﺐ اﺳﺘﺠﺎﺑﺘﻚ وﺣﺎﻟﺘﻚ ﻣﻦ أﺟﻞ ﺗﺤﺪﯾﺪ ﺟﺮﻋﺔ ﻣﺎﯾﻜﺎﻣﯿﻦ اﻟﻼزﻣﺔ. وﻣﻊ ذﻟﻚ، إذا ﻛﻨﺖ ﻗﻠﻘًﺎ ﻣﻦ أﻧﻚ رﺑﻤﺎ ﻗﺪ</p><p dir="RTL">اﺳﺘﻌﻤﻠﺖ ﻣﺎﯾﻜﺎﻣﯿﻦ ﺑﻜﻤﯿﺔ أﻛﺒﺮ ﻣﻦ اﻟﻤﻄﻠﻮﺑﺔ، ﻓﺘﺤﺪث إﻟﻰ اﻟﻄﺒﯿﺐ أو أﺧﺼﺎﺋﻲ رﻋﺎﯾﺔ ﺻﺤﯿﺔ آﺧﺮ ﻋﻠﻰ اﻟﻔﻮر.</p><p>&nbsp;</p><p dir="RTL">.b<u>&nbsp; ﻓﻲ ﺣﺎﻟﺔ ﻧﺴﯿﺎن اﺳﺘﻌﻤﺎل ﻣﺎﯾﻜﺎﻣﯿﻦ</u></p><p dir="RTL">ﯾﺮاﻗﺐ اﻟﻄﺒﯿﺐ اﺳﺘﺠﺎﺑﺘﻚ وﺣﺎﻟﺘﻚ ﻣﻦ أﺟﻞ ﺗﺤﺪﯾﺪ ﻧﻮع اﻟﻌﻼج ﻣﺎﯾﻜﺎﻣﯿﻦ اﻟﻼزم ﻟﻚ. وﻣﻊ ذﻟﻚ، إذا ﻛﻨﺖ ﻗﻠﻘًﺎ ﻣﻦ أﻧﻚ رﺑﻤﺎ</p><p dir="RTL">ﻗﺪ ﻧﺴﯿﺖ أﺧﺬ ﺟﺮﻋﺔ، ﻓﺘﺤﺪث إﻟﻰ اﻟﻄﺒﯿﺐ أو أﺧﺼﺎﺋﻲ رﻋﺎﯾﺔ ﺻﺤﯿﺔ آﺧﺮ ﻋﻠﻰ اﻟﻔﻮر.</p><p>&nbsp;</p><p dir="RTL">.c<u> &nbsp;ﻓﻲ ﺣﺎﻟﺔ اﻟﺘﻮﻗﻒ ﻋﻦ اﺳﺘﻌﻤﺎل ﻣﺎﯾﻜﺎﻣﯿﻦ</u></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">ي اﺳﺘﻔﺴﺎرات إﺿﺎﻓﯿﺔ ﺣﻮل اﺳﺘﻌﻤﺎل ھﺬا اﻟﻤﻨﺘﺞ، ﻓﯿﻨﺒﻐﻲ اﺳﺘﺸﺎرة اﻟﻄﺒﯿﺐ أو اﻟﺼﯿﺪﻟﻲ.</p><p>&nbsp;</p><p dir="RTL">ﻻ ﯾﻮﺟﺪ. إذا ﻛﺎﻧﺖ ﻟﺪﯾﻚ أ</p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;</strong></p><p dir="RTL"><strong>-a&nbsp; اﻟﺘﻔﺎﻋﻼت اﻟﻌﻜﺴﯿﺔ اﻟﺨﻄﯿﺮة اﻟﺴﺮﯾﺮﯾﺔ</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>اﺿﻄﺮاب ﻓﻲ اﻟﺪم:</strong> ﻗﺪ ﯾﺤﺪث ﻧﻘﺺ ﻓﻲ اﻟﻜﺮﯾﺎت اﻟﺒﯿﺾ *)ﻧﺴﺒﺔ اﻟﺤﺪوث ﻏﯿﺮ ﻣﻌﺮوﻓﺔ(، أو ﻗﻠﺔ ﻓﻲ اﻟﻌﺪﻻت )ﻧﺴﺒﺔ اﻟﺤﺪوث<strong> </strong>(%1.1، أو ﻓﻘﺮ اﻟﺪم اﻻﻧﺤﻼﻟﻲ )ﺑﻤﺎ ﯾﺸﻤﻞ اﻧﺤﻼل اﻟﺪم داﺧﻞ اﻷوﻋﯿﺔ؛ *ﻧﺴﺒﺔ اﻟﺤﺪوث ﻏﯿﺮ ﻣﻌﺮوﻓﺔ(، أو اﻟﺘﺨﺜﺮ اﻟﻤﻨﺘﺜﺮ داﺧﻞ اﻷوﻋﯿﺔ )ﻧﺴﺒﺔ اﻟﺤﺪوث ﻏﯿﺮ ﻣﻌﺮوﻓﺔ( أو ﻧﻘﺺ اﻟﺼﻔﯿﺤﺎت. ﺗﺠﺐ ﻣﺮاﻗﺒﺔ اﻟﻤﺮﺿﻰ ﻋﻦ ﻛﺜﺐ ﺑﺈﺟﺮاء اﻟﻔﺤﻮﺻﺎت</p><p dir="RTL">ﺑﺎﻧﺘﻈﺎم،&nbsp;&nbsp; وإﻟﻰ ﻏﯿﺮ ذﻟﻚ. وإذا ﺗﻤﺖ ﻣﻼﺣﻈﺔ أي ﺷﻲء ﻏﯿﺮ طﺒﯿﻌﻲ ﻛﮭﺬه اﻟﻤﺬﻛﻮرة، ﻓﯿﺠﺐ اﺗﺨﺎذ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ، ﻣﺜﻞ</p><p dir="RTL">إﯾﻘﺎف اﻟﻌﻼج.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ﺑﺎﻹﺿﺎﻓﺔ، رﺑﻤﺎ ﯾﺤﺪث ﻓﻘﺮ اﻟﺪم اﻻﻧﺤﻼﻟﻲ ﺑﻌﺪ أﺧﺬ اﻟﻤﻨﺘﺞ ﻣﺒﺎﺷﺮةً، ﻟﺬﻟﻚ، إذا ﺗﻤﺖ ﻣﻼﺣﻈﺔ اﻹﺻﺎﺑﺔ</p><p dir="RTL">ﺑﺎﻧﺤﻼل اﻟﺪم، ﯾﺠﺐ اﺗﺨﺎذ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ، ﻣﺜﻞ إﯾﻘﺎف اﻟﻌﻼج.</p><p>&nbsp;</p><p dir="RTL"><strong>ﺻﺪﻣﺔ، أو ﺗﻔﺎﻋﻼت ﺗﺄﻗّﺎﻧﯿﺔ:</strong> ﻗﺪ ﺗﺤﺪث ﺻﺪﻣﺔ أو ﺗﻔﺎﻋﻼت ﺗﺄﻗّﺎﻧﯿﺔ *)ﻧﺴﺒﺔ اﻟﺤﺪوث ﻏﯿﺮ ﻣﻌﺮوﻓﺔ.( ﺗﺠﺐ ﻣﺮاﻗﺒﺔ اﻟﻤﺮﺿﻰ</p><p dir="RTL">ﻋﻦ ﻛﺜﺐ، وﯾﺠﺐ اﻟﺘﻮﻗﻒ ﻋﻦ أﺧﺬ ھﺬا اﻟﻤﻨﺘﺞ إذا ﺣﺪﺛﺖ أي أﺷﯿﺎء ﻏﯿﺮ طﺒﯿﻌﯿﺔ، ﻣﺜﻞ اﻧﺨﻔﺎض ﺿﻐﻂ اﻟﺪم، أواﻟﺸﻌﻮر ﺑﺎﻷﻟﻢ</p><p dir="RTL">ﻓﻲ ﺣﻠﻖ اﻟﻔﻢ، أو ﺿﯿﻖ اﻟﺘﻨﻔﺲ، أو ﺗﻮ&nbsp;&nbsp;ﱡرد&nbsp;اﻟﺠﺴﻢ ﺑﺎﻟﻜﺎﻣﻞ، أو اﻟﻮذﻣﺔ اﻟﻮﻋﺎﺋﯿﺔ، أو اﻟﺸﺮى، أو إﻟﻰ ﻏﯿﺮ ذﻟﻚ. وإذا ﻟﺰم اﻷﻣﺮ،</p><p dir="RTL">ﯾﺠﺐ اﺗﺨﺎذ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ ﻣﺜﻞ ﻣﻌﺎﻟﺠﺔ اﻟﻤﺴﻠﻚ اﻟﮭﻮاﺋﻲ أو ﺗﻨﺎول اﻷدرﯾﻨﺎﻟﯿﻦ أو اﻟﺴﺘﯿﺮوﯾﺪات أو ﻣﻀﺎدات اﻟﮭﺴﺘﺎﻣﯿﻦ،</p><p dir="RTL">إﻟﻰ ﻏﯿﺮ ذﻟﻚ. <strong>ﺧﻠﻞ وظﺎﺋﻒ اﻟﻜﺒﺪ أو اﻟﯿﺮﻗﺎن:</strong> ﻗﺪ ﯾﺤﺪث ﺧﻠﻞ ﻓﻲ وظﺎﺋﻒ اﻟﻜﺒﺪ ﻣﻊ ارﺗﻔﺎع ﻓﻲ اﻹﻧﺰﯾﻢ اﻟﻨﺎﻗﻞ ﻷﻣﯿﻦ اﻷﺳﺒﺎرﺗﺎت AST)<strong> </strong>أو (GOT أو اﻹﻧﺰﯾﻢ اﻟﻨﺎﻗﻞ ﻷﻣﯿﻦ اﻷﻻﻧﯿﻦ ALT) أو (GPT، أو اﻹﻧﺰﯾﻢ اﻟﻨﺎﻗﻞ ﻟﻐﺎﻣﺎ اﻟﻐﻠﻮﺗﺎﻣﯿﻞ (GGT) أو إﻧﺰﯾﻢ اﻟﻔﻮﺳﻔﺎﺗﺎز اﻟﻘﻠﻮي (ALP)، أو إﻟﻰ ﻏﯿﺮ ذﻟﻚ، وﺑﺎﻹﺿﺎﻓﺔ، ﻗﺪ ﯾﺤﺪث اﻟﯿﺮﻗﺎن *)ﻧﺴﺒﺔ اﻟﺤﺪوث ﻏﯿﺮ ﻣﻌﺮوﻓﺔ.( ﺗﺠﺐ ﻣﺮاﻗﺒﺔ</p><p>&nbsp;</p><p dir="RTL">ي ﺷﻲء ﻏﯿﺮ طﺒﯿﻌﻲ ﻛﮭﺬه اﻟﻤﺬﻛﻮرة،</p><p>&nbsp;</p><p dir="RTL">اﻟﻤﺮﺿﻰ ﻋﻦ ﻛﺜﺐ ﺑﺈﺟﺮاء اﻟﻔﺤﻮﺻﺎت ﺑﺎﻧﺘﻈﺎم، وإﻟﻰ ﻏﯿﺮ ذﻟﻚ. وإذا ﺗﻤﺖ ﻣﻼﺣﻈﺔ أ</p><p dir="RTL">ﻓﯿﺠﺐ اﺗﺨﺎذ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ، ﻣﺜﻞ إﯾﻘﺎف اﻟﻌﻼج.</p><p>&nbsp;</p><p dir="RTL"><strong>اﻟﻔﺸﻞ اﻟﻜﻠﻮي اﻟﺤﺎد:</strong> ﻗﺪ ﯾﺤﺪث اﻟﻔﺸﻞ ﻛﻠﻮى ﺧﻄﯿﺮ ﻣﺜﻞ اﻟﻔﺸﻞ اﻟﻜﻠﻮي اﻟﺤﺎد *)ﻧﺴﺒﺔ اﻟﺤﺪوث ﻏﯿﺮ ﻣﻌﺮوﻓﺔ.( ﺗﺠﺐ ﻣﺮاﻗﺒﺔ</p><p>&nbsp;</p><p dir="RTL">ي ﺷﻲء ﻏﯿﺮ طﺒﯿﻌﻲ ﻛﮭﺬه اﻟﻤﺬﻛﻮرة،</p><p>&nbsp;</p><p dir="RTL">اﻟﻤﺮﺿﻰ ﻋﻦ ﻛﺜﺐ ﺑﺈﺟﺮاء اﻟﻔﺤﻮﺻﺎت ﺑﺎﻧﺘﻈﺎم، وإﻟﻰ ﻏﯿﺮ ذﻟﻚ. وإذا ﺗﻤﺖ ﻣﻼﺣﻈﺔ أ</p><p dir="RTL">ﻓﯿﺠﺐ اﺗﺨﺎذ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ، ﻣﺜﻞ إﯾﻘﺎف اﻟﻌﻼج.</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>&nbsp; ﺗﻘﺸﺮ اﻷﻧﺴﺠﺔ اﻟﻤﺘﻤﻮﺗﺔ اﻟﺒﺸﺮوﯾﺔ اﻟﺘﺴﻤﻤﻲ (TEN)، أو اﻟﻤﺘﻼزﻣﺔ اﻟﻌﯿﻨﯿﺔ اﻟﻤﺨﺎطﯿﺔ اﻟﺠﻠﺪﯾﺔ )ﻣﺘﻼزﻣﺔ ﺳﺘﯿﻔﻨﺲ &nbsp;&nbsp;ﺟﻮﻧﺴﻮن( أو اﻟﺤﻤﺎﻣﻰ ﻣﺘﻌﺪدة اﻷﺷﻜﺎل</strong>: ﺗﺠﺐ ﻣﺮاﻗﺒﺔ اﻟﻤﺮﺿﻰ ﻋﻦ ﻛﺜﺐ ﻧﻈ&nbsp; ًﺮا&nbsp;ﻻﺣﺘﻤﺎﻟﯿﺔ ﺣﺪوث ﺗﻘﺸﺮ ﺗﺴﻤﻤﻲ ﻓﻲ<strong> </strong>اﻷﻧﺴﺠﺔ اﻟﻤﺘﻤﻮﺗﺔ اﻟﺒﺸﺮوﯾﺔ أو اﻟﻤﺘﻼزﻣﺔ اﻟﻌﯿﻨﯿﺔ اﻟﻤﺨﺎطﯿﺔ اﻟﺠﻠﺪﯾﺔ أو اﻟﺤﻤﺎﻣﻰ ﻣﺘﻌﺪدة اﻷﺷﻜﺎل *)ﻧﺴﺒﺔ ﺣﺪوث ﻛﻞ ﻣﻨﮭﺎ</p><p>&nbsp;</p><p dir="RTL">ي ﺷﻲء ﻏﯿﺮ طﺒﯿﻌﻲ أﺛﻨﺎء ﻓﺘﺮة اﻟﻌﻼج، ﯾﺠﺐ اﺗﺨﺎذ اﻟﺘﺪاﺑﯿﺮ اﻟﻤﻨﺎﺳﺒﺔ، ﻣﺜﻞ اﻟﺘﻮﻗﻒ ﻋﻦ</p><p>&nbsp;</p><p dir="RTL">ﻏﯿﺮ ﻣﻌﺮوﻓﺔ.( ﻓﻲ ﺣﺎل ﻣﻼﺣﻈﺔ أ</p><p dir="RTL">اﺳﺘﺨﺪام ھﺬا اﻟﻤﺴﺘﺤﻀﺮ.</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>*ﻧﺴﺒﺔ اﻟﺤﺪوث ﻏﯿﺮ ﻣﻌﺮوﻓﺔ:</strong> ﻟﻢ ﯾﺘﻢ اﺣﺘﺴﺎب ﻧﺴﺒﺔ اﻟﺤﺪوث ﺑﺴﺒﺐ اﻟﺘﻘﺎرﯾﺮ اﻟﺘﻲ ﺗﺄﺗﻲ ﺑﺸﻜﻞ ﺗﻠﻘﺎﺋﻲ.</p><p><strong>&nbsp;</strong></p><p>-b&nbsp; ﺗﻔﺎﻋﻼت ﻋﻜﺴﯿﺔ أﺧﺮى</p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top; width:223px"><p dir="RTL">ﻧﺴﺒﺔ&nbsp;اﻟﺤﺪوث&nbsp;ﻏﯿﺮ ﻣﻌﺮوﻓﺔ</p></td><td style="vertical-align:top; width:312px"><p>%5 &gt; - %0.1&le;</p></td><td style="vertical-align:top; width:195px"><p>%5 &le;</p></td><td style="vertical-align:top; width:139px"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top; width:223px"><p>&nbsp;</p></td><td style="vertical-align:top; width:312px"><p dir="RTL">ارﺗﻔﺎع&nbsp; &nbsp; &nbsp;اﻹﻧﺰﯾﻢ&nbsp; اﻟﻨﺎﻗﻞ&nbsp;ﻷﻣﯿﻦ (GOT أو AST) اﻷﺳﺒﺎرﺗﺎت</p><p dir="RTL">ارﺗﻔﺎع&nbsp;&nbsp;إﻧﺰﯾﻢ&nbsp;&nbsp;اﻟﻔﻮﺳﻔﺎﺗﺎز&nbsp; &nbsp;اﻟﻘﻠﻮي ،(ALP)</p><p dir="RTL">ارﺗﻔﺎع&nbsp; اﻹﻧﺰﯾﻢ&nbsp; اﻟﻨﺎزع&nbsp; ﻟﮭﯿﺪروﺟﯿﻦ</p><p dir="RTL">اﻟﻼﻛﺘﺎت (LDH)،</p><p dir="RTL">ارﺗﻔﺎع&nbsp; &nbsp; اﻹﻧﺰﯾﻢ&nbsp; &nbsp; اﻟﻨﺎﻗﻞ&nbsp; ﻟﺠﺎﻣﺎ</p><p dir="RTL">اﻟﻐﻠﻮﺗﺎﻣﯿﻞ (GGT)</p></td><td style="vertical-align:top; width:195px"><p dir="RTL">، ارﺗﻔﺎع&nbsp; اﻹﻧﺰﯾﻢ&nbsp; اﻟﻨﺎﻗﻞ</p><p dir="RTL">ﻷﻣﯿﻦ&nbsp; اﻷﻻﻧﯿﻦ&nbsp; ALT)</p><p>(GPT أو</p></td><td style="vertical-align:top; width:139px"><p dir="RTL">ﻛﺒﺪﯾﺔ</p></td></tr><tr><td style="vertical-align:top; width:223px"><p dir="RTL">ﻧﻘﺺ&nbsp;ﻣﻐﻨﯿﺴﯿﻮم&nbsp;اﻟﺪم،</p><p dir="RTL">وﻧﻘﺺ ﻛﺎﻟﺴﯿﻮم اﻟﺪم</p></td><td style="vertical-align:top; width:312px"><p dir="RTL">ﻓﺮط ﺑﻮﺗﺎﺳﯿﻮم اﻟﺪم،</p><p dir="RTL">ﻧﻘﺺ ﺑﻮﺗﺎﺳﯿﻮم اﻟﺪم،</p></td><td style="vertical-align:top; width:195px"><p>&nbsp;</p></td><td style="vertical-align:top; width:139px"><p dir="RTL">أﯾﻀﯿﺔ</p></td></tr><tr><td style="vertical-align:top; width:223px"><p>&nbsp;</p></td><td style="vertical-align:top; width:312px"><p dir="RTL">ﻛﺜﺮة اﻟﯿﻮزﯾﻨﯿﺎت</p></td><td style="vertical-align:top; width:195px"><p>&nbsp;</p></td><td style="vertical-align:top; width:139px"><p dir="RTL">دﻣﻮﯾﺔ</p></td></tr><tr><td style="vertical-align:top; width:223px"><p>&nbsp;</p></td><td style="vertical-align:top; width:312px"><p dir="RTL">طﻔﺢ ﺟﻠﺪي</p></td><td style="vertical-align:top; width:195px"><p>&nbsp;</p></td><td style="vertical-align:top; width:139px"><p dir="RTL">ﺟﻠﺪﯾﺔ</p></td></tr><tr><td style="vertical-align:top; width:223px"><p>&nbsp;</p></td><td style="vertical-align:top; width:312px"><p dir="RTL">ارﺗﻔﺎع ﺿﻐﻂ اﻟﺪم، واﻟﺨﻔﻘﺎن اﻟﺴﺮﯾﻊ ﻟﻠﻘﻠﺐ</p></td><td style="vertical-align:top; width:195px"><p>&nbsp;</p></td><td style="vertical-align:top; width:139px"><p dir="RTL">&nbsp;اﻟﻘﻠﺐ واﻷوﻋﯿﺔ</p><p dir="RTL">اﻟﺪﻣﻮﯾﺔ</p></td></tr><tr><td style="vertical-align:top; width:223px"><p dir="RTL">اﻟﻘﻲء واﻟﻐﺜﯿﺎن</p></td><td style="vertical-align:top; width:312px"><p dir="RTL">اﻹﺳﮭﺎل</p></td><td style="vertical-align:top; width:195px"><p>&nbsp;</p></td><td style="vertical-align:top; width:139px"><p dir="RTL">ﻣﻌﻮﯾﺔ</p></td></tr><tr><td style="vertical-align:top; width:223px"><p dir="RTL">اﻧﺨﻔﺎض&nbsp;ﺗﺼﻔﯿﺔ اﻟﻜﺮﯾﺎﺗﯿﻨﯿﻦ</p></td><td style="vertical-align:top; width:312px"><p dir="RTL">ارﺗﻔﺎع اﻟﻜﺮﯾﺎﺗﯿﻨﯿﻦ،&nbsp;وارﺗﻔﺎع ﻧﯿﺘﺮوﺟﯿﻦ ﯾﻮرﯾﺎ اﻟﺪم (BUN)</p></td><td style="vertical-align:top; width:195px"><p>&nbsp;</p></td><td style="vertical-align:top; width:139px"><p dir="RTL">ﻛﻠﻮﯾﺔ</p></td></tr><tr><td style="vertical-align:top; width:223px"><p dir="RTL">ارﺗﻔﺎع &nbsp;ﻛﯿﻨﺎز&nbsp; اﻟﻜﺮﯾﺎﺗﯿﻦ</p><p dir="RTL">CK&nbsp; )ﻓﻮﺳﻔﻮﻛﯿﻨﺎز</p><p dir="RTL">اﻟﻜﺮﯾﺎﺗﯿﻦ&nbsp;(CPK،</p><p dir="RTL">وارﺗﻔﺎع&nbsp; ﻧﺴﺒﺔ اﻟﻤﯿﻮﺟﻠﻮﺑﯿﻦ ﻓﻲ&nbsp;اﻟﺪم،</p><p dir="RTL">واﻟﺤﻤﻰ</p></td><td style="vertical-align:top; width:312px"><p dir="RTL">اﻟﺘﮭﺎب ورﯾﺪي،&nbsp;&nbsp; وﺻﺪاع،&nbsp;&nbsp; اﻟﺘﮭﺎب</p><p dir="RTL">اﻟﻤﻔﺎﺻﻞ اﻟﺮوﻣﺎﺗﻮﯾﺪي، وأﻟﻢ وﻋﺎﺋﻲ،</p><p dir="RTL">واﻟﺮﺟﻔﺔ</p></td><td style="vertical-align:top; width:195px"><p>&nbsp;</p></td><td style="vertical-align:top; width:139px"><p dir="RTL">أﺧﺮى</p></td></tr></tbody></table><p><strong>ﻣﻼﺣﻈﺔ:</strong>&nbsp;ﯾُﺮﺟﻰ اﻻﺗﺼﺎل ﺑﺸﺮﻛﺔ أدوﯾﺔ اﻟﺤﻜﻤﺔ ﻓﻲ ﺣﺎﻟﺔ ﺣﺪوث أي ﺗﻔﺎﻋﻼت ﻋﻜﺴﯿﺔ ﺧﻄﯿﺮة ﺗﺘﻌﻠﻖ ﺑﺎﺳﺘﺨﺪام ھﺬا اﻟﻤﻨﺘﺞ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;</strong></p><p dir="RTL">ﯾﺤﻔﻆ ﻓﻲ درﺟﺔ ﺣﺮارة ﺗﻘﻞ ﻋﻦ &ordm;30 درﺟﺔ ﻣﺌﻮﯾﺔ، ﺑﻌﯿﺪًا ﻋﻦ اﻟﻀﻮء.</p><p dir="RTL">ﯾﺠﻮز ﺗﺨﺰﯾﻦ اﻟﻤﺴﺘﺤﻀﺮ اﻟﻤﺮﻛﺐ ﻓﻲ اﻟﻘﻨﯿﻨﺔ اﻷﺻﻠﯿﺔ ﻟﻤﺪة 24 ﺳﺎﻋﺔ ﻓﻲ درﺟﺔ ﺣﺮارة اﻟﻐﺮﻓﺔ، &deg;25 درﺟﺔ ﻣﺌﻮﯾﺔ &deg;77)</p><p dir="RTL">درﺟﺔ ﻓﮭﺮﻧﮭﺎﯾﺖ.(</p><p dir="RTL">ﺗﺠﺐ ﺣﻤﺎﯾﺔ ﻣﺤﻠﻮل اﻟﺤﻘﻦ اﻟﻮرﯾﺪي اﻟﻤﺨﻔﱠﻒ ﻣﻦ اﻟﻀﻮء، وﯾﺠﻮز ﺗﺨﺰﯾﻨﮫ ﻟﻤﺪة 24 ﺳﺎﻋﺔ ﻓﻲ درﺟﺔ ﺣﺮارة اﻟﻐﺮﻓﺔ، &deg;25</p><p dir="RTL">درﺟﺔ ﻣﺌﻮﯾﺔ &deg;77) درﺟﺔ ﻓﮭﺮﻧﮭﺎﯾﺖ.(</p><p>&nbsp;</p><p dir="RTL">ﻻ ﺗﺘﺮك اﻷدوﯾﺔ ﻓﻲ ﻣﺘﻨﺎول أﯾﺪي اﻷطﻔﺎل</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اﻟﻌﺒﻮة</strong></p><p dir="RTL">ﻗﻨﯿﻨﺎت. ﻣﺎﯾﻜﺎﻣﯿﻦ :50 ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ 50 ﻣﻠﺠﻢ )ﻗﻮﯾﺔ اﻟﻤﻔﻌﻮل( اﻟﺴﻮاغ: اﻟﻼﻛﺘﻮز، وﺣﻤﺾ اﻟﺴﺘﺮﯾﻚ اﻟﻼﻣﺎﺋﻲ، وھﯿﺪروﻛﺴﯿﺪ اﻟﺼﻮدﯾﻮم</p><p>&nbsp;</p><p>إرﺷﺎدات اﻟﺘﺮﻛﯿﺐ واﻟﺘﺨﻔﯿﻒ</p><p dir="RTL">ﯾُﺮﺟﻰ ﻗﺮاءة ھﺬا اﻟﻤﻘﻄﻊ ﻛﻠﮫ ﺑﻌﻨﺎﯾﺔ ﻗﺒﻞ ﺑﺪء اﻟﺘﺮﻛﯿﺐ. اﻟﻤﺎدة اﻟ ُﻤﺨ ِﻔّﻔﺔ اﻟﻤﺴﺘﺨﺪﻣﺔ ﻟﻠﺘﺮﻛﯿﺐ واﻟﺘﺨﻔﯿﻒ ﺗﻜﻮن ﺣﻘﻦ ﻛﻠﻮرﯾﺪ اﻟﺼﻮدﯾﻮم ﺑﻨﺴﺒﺔ %0.9، ﻧﻮع اﻹﻋﺪاد اﻟﻤﻌﻘﻢ ﻏﯿﺮ اﻟﺤﺮاري&nbsp; (USP) )ﺑﺪون ﻋﺎﻣﻞ ﻛﺎﺑﺢ ﻟﻠﺒﻜﺘﯿﺮﯾﺎ.( أو ﺑﺪﻻً&nbsp;ﻣﻦ ذﻟﻚ، ﯾﻤﻜﻦ اﺳﺘﺨﺪام ﺣﻘﻦ اﻟﺪﻛﺴﺘﺮوز، ﻧﻮع اﻹﻋﺪاد اﻟﻤﻌﻘﻢ</p><p dir="RTL">ﻏﯿﺮ اﻟﺤﺮاري (USP)، ﻟﺘﺮﻛﯿﺐ وﺗﺨﻔﯿﻒ ﻣﺴﺘﺤﻀﺮ ﻣﺎﯾﻜﺎﻣﯿﻦ. ﯾﺘﻢ ﺗﺤﻀﯿﺮ ﻣﺤﺎﻟﯿﻞ اﻟﺤﻘﻦ اﻟﻮرﯾﺪي ﻛﻤﺎ ﯾﻠﻲ:</p><p>&nbsp;</p><p>اﻟﺘﺮﻛﯿﺐ:</p><p dir="RTL">ﻗﻨﯿﻨﺔ ﻣﺎﯾﻜﺎﻣﯿﻦ 50 ﻣﻠﺠﻢ</p><p>&nbsp;</p><p dir="RTL">.1&nbsp; ﺗﺠﺐ إزاﻟﺔ اﻟﻐﻄﺎء اﻟﺒﻼﺳﺘﯿﻜﻲ ﻣﻦ اﻟﻘﻨﯿﻨﺔ وﺗﻄﮭﯿﺮ اﻟﺴﺪادة ﺑﺎﺳﺘﺨﺪام اﻟﻜﺤﻮل</p><p dir="RTL">.2&nbsp; ﯾﺠﺐ ﺣﻘﻦ ﺧﻤﺴﺔ ﻣﻠﺠﻢ ﻣﻦ ﻣﺤﻠﻮل ﻛﻠﻮرﯾﺪ اﻟﺼﻮدﯾﻮم 9ﻣﺠﻢ/ﻣﻞ (%0.9) ﻟﻠﺤﻘﻦ اﻟﻮرﯾﺪي أو ﻣﺤﻠﻮل اﻟﺠﻠﻮﻛﻮز</p><p dir="RTL">50 ﻣﺠﻢ/ﻣﻞ (%5) ﻟﻠﺤﻘﻦ اﻟﻮرﯾﺪي )ﻣﻦ زﺟﺎﺟﺔ أو ﻋﺒﻮة 100 ﻣﻞ( ﻓﻲ ﺑﯿﺌﺔ ﻣﻌﻘﻤﺔ وﺑﺒﻂء داﺧﻞ ﻛﻞ اﻟﻘﻨﯿﻨﺔ ﺑﻄﻮل اﻟﺠﺎﻧﺐ</p><p dir="RTL">اﻟﺪاﺧﻠﻲ. ﺳﯿﻨﺘﺞ ﻋﻦ اﻟﺘﺮﻛﯿﺰ رﻏﻮةً، وﻟﻜﻦ ﯾﻨﺒﻐﻲ ﺑﺬل ﻛﻞ ﺟﮭﺪ ﻣﻤﻜﻦ ﻟﺘﻘﻠﯿﻞ ﻛﻤﯿﺔ اﻟﺮﻏﻮة اﻟﻨﺎﺗﺠﺔ.</p><p>&nbsp;</p><p dir="RTL">اﺳﺘﺨﺪام اﻟﻤﺤﻠﻮل اﻟﻤﺮ&nbsp;&nbsp; ﱠﻛﺰ ﻋﻠﻰ ﯾﺠﺐ</p><p>&nbsp;</p><p dir="RTL">ﺳﯿﺬوب اﻟﻤﺴﺤﻮق ﺑﺎﻟﻜﺎﻣﻞ.</p><p>&nbsp;</p><p dir="RTL">.3&nbsp; ﯾﺠﺐ ﺗﺪوﯾﺮ &nbsp;اﻟﻘﻨﯿﻨﺔ ﺑﺮﻓﻖ. ﻻ ﺗﻘﻢ ﺑﺮﺟﮭﺎ.</p><p>&nbsp;</p><p dir="RTL">ﻣﺨﺼﺼﺔ ﻟﻼﺳﺘﻌﻤﺎل ﻟﻤﺮة واﺣﺪة ﻓﻘﻂ. ﻟﺬﻟﻚ ﯾُﺮﺟﻰ اﻟﺘﺨﻠﺺ ﻣﻦ اﻟﻤﺤﻠﻮل اﻟﻤﺮ&nbsp;&nbsp; ﱠﻛﺰ&nbsp;اﻟﻤﺮ&nbsp;&nbsp; ﱠﻛﺐ&nbsp;ﻏﯿﺮ اﻟﻤﺴﺘﺨﺪم اﻟﻘﻨﯿﻨﺔ</p><p>&nbsp;</p><p dir="RTL">اﻟﻔﻮر.</p><p>&nbsp;</p><p dir="RTL">ﻋﻠﻰ اﻟﻔﻮر.</p><p dir="RTL">.4&nbsp; ﯾﺠﺐ ﺳﺤﺐ &nbsp;&nbsp;اﻟﻤﺤﻠﻮل اﻟﻤﺮ&nbsp;&nbsp; ﱠﻛﺰ اﻟﻤﺮ&nbsp;&nbsp; ﱠﻛﺐ ﺑﺄﻛﻤﻠﮫ ﻣﻦ ﻛﻞ ﻗﻨﯿﻨﺔ، وإرﺟﺎﻋﮫ إﻟﻰ زﺟﺎﺟﺔ أو ﻋﺒﻮة اﻟﺴﺤﺐ اﻟﻮرﯾﺪي</p><p dir="RTL">اﻟﺬي&nbsp;أُ&nbsp;ِ ّﺧﺬ&nbsp;ﻣﻨﮭﺎ&nbsp;ﻓﻲ اﻷﺻﻞ. ﯾﺠﺐ اﺳﺘﻌﻤﺎل ﻣﺤﻠﻮل اﻟﺤﻘﻦ اﻟﻮرﯾﺪي اﻟﻤﺨﻔﻒ ﻋﻠﻰ اﻟﻔﻮر. ﺗﻢ ﺗﺤﺪﯾﺪ اﻻﺳﺘﻘﺮار اﻟﻜﯿﻤﯿﺎﺋﻲ</p><p dir="RTL">واﻟﻤﺎدي &nbsp;&nbsp;أﺛﻨﺎء اﻻﺳﺘﺨﺪام، وﯾﺴﺘﻤﺮ ﻟﻤﺪة 96 ﺳﺎﻋﺔ ﻓﻲ درﺟﺔ ﺣﺮارة &deg;25 درﺟﺔ ﻣﺌﻮﯾﺔ، وذﻟﻚ ﻋﻨﺪ اﻟﺤﻤﺎﯾﺔ ﻣﻦ اﻟﻀﻮء</p><p dir="RTL">واﻟﺘﺨﻔﯿﻒ ﺑﺎﻟﻄﺮﯾﻘﺔ اﻟﻤﻮﺻﻮﻓﺔ أﻋﻼه.</p><p dir="RTL">.5&nbsp; ﯾﺠﺐ ﻗﻠﺐ &nbsp;&nbsp;زﺟﺎﺟﺔ أو ﻋﺒﻮة ﻣﺤﻠﻮل اﻟﺤﻘﻦ اﻟﻮرﯾﺪي ﺑﺮﻓﻖ ﻟﻨﺸﺮ اﻟﻤﺤﻠﻮل اﻟﻤﺨﻔﻒ، وﻟﻜﻦ ﻻ ﯾﺠﻮز رﺟﮭﺎ ﻣﻨﻌًﺎ</p><p dir="RTL">ﻟﺘﻜﻮﯾﻦ اﻟﻔﻘﺎﻋﺎت.&nbsp; ﻻ ﺗﺴﺘﺨﺪم اﻟﻤﺤﻠﻮل إذا ﻛﺎن ﻏﺎﺋﻤﺎ أو ﺑﮫ ﺗﺮﺳﯿﺒﺎت.</p><p dir="RTL">.6&nbsp; ﯾﺠﺐ وﺿﻊ زﺟﺎﺟﺔ أو ﻋﺒﻮة ﻣﺤﻠﻮل اﻟﺤﻘﻦ اﻟﻮرﯾﺪي اﻟﺘﻲ ﺗﺤﺘﻮي ﻋﻠﻰ ﻣﺤﻠﻮل اﻟﺤﻘﻦ اﻟﻮرﯾﺪي اﻟﻤﺨﻔﻒ ﻓﻲ ﻋﺒﻮة</p><p dir="RTL">ﻣﻌﺘﻤﺔ ﯾﻤﻜﻦ ﻗﻔﻠﮭﺎ، وذﻟﻚ ﻟﺤﻤﺎﯾﺘﮭﺎ ﻣﻦ اﻟﻀﻮء.&nbsp; ﻻ ﯾﻠﺰم ﺗﻐﻄﯿﺔ وﺣﺪة اﻟﺘﻘﻄﯿﺮ ﻟﻠﺤﻘﻦ اﻟﻮرﯾﺪي أو اﻷﻧﺒﻮب.</p><p dir="RTL">.7&nbsp; ﺑﻌﺪ اﻟﺘﺮﻛﯿﺐ واﻟﺘﺨﻔﯿﻒ، ﯾﺠﺐ أﺧﺬ اﻟﻤﺤﻠﻮل ﻋﺒﺮ اﻟﺤﻘﻦ اﻟﻮرﯾﺪي ﺧﻼل ﺳﺎﻋﺔ واﺣﺪة ﺗﻘﺮﯾﺒًﺎ.</p><p>&nbsp;</p><p>اﺣﺘﯿﺎطﺎت اﻻﺳﺘﺨﺪام</p><p>&nbsp;</p><p dir="RTL">اﺣﺘﯿﺎطﺎت اﻟﺘﺤﻀﯿﺮ: ﻻ ﺗﺮج ﻋﺒﻮة ﻣﺤﻠﻮل اﻟﺤﻘﻦ اﻟﻮرﯾﺪي ﺑﻘﻮة ﻹذاﺑﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﻷﻧﮫ ﯾﺸﻜﻞ اﻟﺮﻏﻮة ﺑﺴﮭﻮﻟﺔ،</p><p dir="RTL">وﺗﺨﺘﻔﻰ اﻟﻔﻘﺎﻋﺎت اﻟﻨﺎﺗﺠﺔ ﺑﺼﻌﻮﺑﺔ. اﺣﺘﯿﺎطﺎت أﺛﻨﺎء ﺗﻨﺎول اﻟﺠﺮﻋﺔ: ﯾﺠﺐ ﺣﻔﻆ ﻣﯿﻜﺎﻓﻨﺠﻦ ﺑﻌﯿﺪًا ﻋﻦ أﺷﻌﺔ اﻟﺸﻤﺲ اﻟﻤﺒﺎﺷﺮة، وذﻟﻚ ﻷن ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﯾﺘﺤﻠﻞ ﺗﺪرﯾﺠﯿًﺎ ﻓﻲ وﺟﻮد اﻟﻀﻮء. ﻋﻨﺪﻣﺎ ﯾُﺴﺘﻐ&nbsp;ﱠﺮق&nbsp;أﻛﺜﺮ ﻣﻦ 6 ﺳﺎﻋﺎت ﻣﻨﺬ ﺑﺪاﯾﺔ اﻟﺘﺤﻀﯿﺮ وإﻟﻰ ﻧﮭﺎﯾﺔ اﻟﺤﻘﻦ اﻟﻮرﯾﺪي، ﻗﻢ ﺑﺤﻤﺎﯾﺔ ﻋﺒﻮة ﻣﺤﻠﻮل اﻟﺤﻘﻦ اﻟﻮرﯾﺪي ﻣﻦ اﻟﻀﻮء. ﻣﻦ ﻧﺎﺣﯿﺔ أﺧﺮى، ﻻ ﺗﻠﺰم ﺣﻤﺎﯾﺔ أﻧﺒﻮب ﻣﺤﻠﻮل اﻟﺤﻘﻦ اﻟﻮرﯾﺪي ﻣﻦ</p><p dir="RTL">اﻟﻀﻮء.</p><p dir="RTL">اﻟﺘﻨﺎﻓﺮ:&nbsp; رﺑﻤﺎ ﻗﺪ ﺗﺤﺪث ﺗﺮﺳﯿﺒﺎت إذا ﺗﻤﺖ إذاﺑﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﺑﺎﻟﺘﺰاﻣﻦ ﻣﻦ اﻟﻌﻘﺎﻗﯿﺮ اﻷﺧﺮى. وﻋﻼوة ﻋﻠﻰ ذﻟﻚ،</p><p dir="RTL">رﺑﻤﺎ ﯾﺼﺒﺢ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ ﻏﯿﺮ ﻣﺴﺘﻘﺮ ﻓﻲ اﻟﻤﺤﻠﻮل اﻷﺳﺎﺳﻲ، ﺣﯿﺚ ﯾﻤﻜﻦ أن ﺗﻘﻞ ﻓﺎﻋﻠﯿﺔ ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ. اﻟﻌﻘﺎﻗﯿﺮ اﻷﺳﺎﺳﯿﺔ اﻟﺘﻲ ﺗُﺤ&nbsp;ِﺪّث ﺗﺮﺳﯿﺒًﺎ ﺑﻌﺪ ﻣﺰﺟﮭﺎ ﻣﻊ ﻣﯿﻜﺎﻓﻨﺠﻦ ﻋﻠﻰ اﻟﻔﻮر: ھﯿﺪروﻛﻠﻮرﯾﺪ اﻟﻔﺎﻧﻜﻮﻣﯿﺴﯿﻦ، وﻛﺒﺮﯾﺘﺎت</p><p dir="RTL">اﻷرﺑﯿﻜﺎﺳﯿﻦ،&nbsp;&nbsp; وﻛﺒﺮﯾﺘﺎت&nbsp;&nbsp; اﻟﺠﻨﺘﺎﻣﯿﺴﯿﻦ،&nbsp;&nbsp; وﺗﻮﺑﺮاﻣﯿﺴﯿﻦ،&nbsp;&nbsp; وﻛﺒﺮﯾﺘﺎت&nbsp;&nbsp; اﻟﺪﯾﺒﯿﻜﺎﺳﯿﻦ،&nbsp;&nbsp; وھﯿﺪروﻛﻠﻮرﯾﺪ&nbsp;&nbsp; اﻟﻤﯿﻨﻮﺳﯿﻜﻠﯿﻦ،</p><p dir="RTL">وﺳﯿﺒﺮوﻓﻠﻮﻛﺴﺎﺳﯿﻦ، وﻣﯿﺴﯿﻼت اﻟﺒﺎزوﻓﻠﻮﻛﺴﺎﺳﯿﻦ، وﺳﯿﻤﯿﺘﯿﺪﯾﻦ، وھﯿﺪروﻛﻠﻮرﯾﺪ اﻟﺪوﺑﻮﺗﺎﻣﯿﻦ، وھﯿﺪروﻛﻠﻮرﯾﺪ اﻟﺪوﻛﺴﺎﺑﺮام،&nbsp;&nbsp;&nbsp; واﻟﺒﻨﺘﺎزوﺳﯿﻦ، وﻣﯿﺴﯿﻼت اﻟﻨﺎﻓﺎﻣﻮﺳﺘﺎت، وﻣﯿﺴﯿﻼت اﻟﺠﺎﺑﯿﻜﺴﺎت، وﺛﯿﺎﻣﯿﻦ ﺛﻨﺎﺋﻲ اﻟﺴﻠﻔﯿﺪ/ھﯿﺪروﻛﻠﻮرﯾﺪ</p><p dir="RTL">اﻟﺒﯿﺮﯾﺪوﻛﺴﯿﻦ/أﺳﯿﺘﺎت&nbsp; اﻟﮭﯿﺪروﻛﺴﻮﺑﺎﻻﻣﯿﻦ، واﻟﻤﯿﻨﺎﺗﺘﺮﯾﻨﻮن، وﻏﻠﻮﺑﻮﻟﯿﻦ ﻣﻨﺎﻋﻲ طﺒﯿﻌﻲ ﺑﺸﺮى ﻣﻌﺎﻟﱠﺞ ﺑﺎﻟﺒﺒﺴﯿﻦ اﻟﻤﺠﻔﻒ</p><p dir="RTL">ﺑﺎﻟﺘﺠﻤﯿﺪ، وھﯿﺪروﻛﻠﻮرﯾﺪ اﻟﺪوﻛﺴﻮ&nbsp; ُروﺑﯿﺴﯿﻦ.</p><p>&nbsp;</p><p dir="RTL">اﻷﻣﺒﯿﺴﯿﻠﯿﻦ،</p><p>&nbsp;</p><p dir="RTL">اﻟﻌﻘﺎﻗﯿﺮ&nbsp; اﻷﺳﺎﺳﯿﺔ&nbsp;&nbsp; اﻟﺘﻲ&nbsp;&nbsp; ﺗﺨﻔﺾ&nbsp;&nbsp; ﻗﻮة&nbsp;&nbsp; ﻣﻔﻌﻮل&nbsp;&nbsp; ﺻﻮدﯾﻮم&nbsp;&nbsp; اﻟﻤﯿﻜﺎﻓﻨﺠﻦ&nbsp;&nbsp; ﺑﻌﺪ&nbsp;&nbsp; اﻟﻤﺰج&nbsp;&nbsp; ﻋﻠﻰ&nbsp;&nbsp; اﻟﻔﻮر:</p><p dir="RTL">وﺳﻠﻔﺎﻣﯿﺜﻮﻛﺴﺎزول/ﺗﺮﯾﻤﯿﺜﻮﺑﺮﯾﻢ، وآﺳﯿﻜﻠﻮﻓﯿﺮ، وﺟﺎﻧﺴﯿﻜﻠﻮﻓﯿﺮ، وأﺳﯿﺘﺎزوﻻﻣﯿﺪ.</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اﻟﻌﺒﻮة</strong></p><p dir="RTL">ﻗﻨﯿﻨﺎت. ﻣﺎﯾﻜﺎﻣﯿﻦ :50 ﺻﻮدﯾﻮم اﻟﻤﯿﻜﺎﻓﻨﺠﻦ 50 ﻣﻠﺠﻢ )ﻗﻮﯾﺔ اﻟﻤﻔﻌﻮل( اﻟﺴﻮاغ: اﻟﻼﻛﺘﻮز، وﺣﻤﺾ اﻟﺴﺘﺮﯾﻚ اﻟﻼﻣﺎﺋﻲ، وھﯿﺪروﻛﺴﯿﺪ اﻟﺼﻮدﯾﻮم</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>ﻟﺸﺮﻛﺔ ﺣﺎﻣﻠﺔ ﺗﺮﺧﯿﺺ اﻟﺘﺴﻮﯾﻖ</p><p dir="RTL">اﺳﺘﻼس ﻓﺎرﻣﺎ اﻟﻤﺤﺪودة</p><p>5-1 Nihonsbashi 2-Honchochuo-ku</p><p dir="RTL">&ndash; اﻟﯿﺎﺑﺎن</p><p>103-8411</p><p dir="RTL">طﻮ<strong>ﻛﯿﻮ</strong></p><p>إﻧﺘﺎج ﺷﺮﻛﺔ اﺳﺘﻼس ﻓﺎرﻣﺎﺗﻚ اﻟﻤﺤﺪودة</p><p>30ﺗﺎﻛﻮﻛﺎ ﻣﺪﯾﻨﺔ ﻣﺼﻨﻊ Toidesakae-machi Takaoka city, Toyama 939-1118 Japan</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            آﺧﺮ ﻣﺮاﺟﻌﺔ ﻟﮭﺬه اﻟﻨﺸﺮة ﻛﺎﻧﺖ ﻓﻲ ﺳﺒﺘﻤﺒﺮ 2018، رﻗﻢ اﻹﺻﺪار2.0
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">
            <div class="p-20 text-center font-20">
                <div class="p-10 bg-red"><i class="fa fa-times-circle"></i>&nbsp;&#x644;&#x645; &#x64A;&#x62A;&#x645; &#x625;&#x62F;&#x62E;&#x627;&#x644; &#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A;  &#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A; &#x644;&#x647;&#x630;&#x627; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621; &#x62D;&#x62A;&#x649; &#x627;&#x644;&#x622;&#x646;</div>
            </div>
    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>